JPH0225625B2 - - Google Patents
Info
- Publication number
- JPH0225625B2 JPH0225625B2 JP56081474A JP8147481A JPH0225625B2 JP H0225625 B2 JPH0225625 B2 JP H0225625B2 JP 56081474 A JP56081474 A JP 56081474A JP 8147481 A JP8147481 A JP 8147481A JP H0225625 B2 JPH0225625 B2 JP H0225625B2
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- acid
- urinary catheter
- urinary
- urine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002485 urinary effect Effects 0.000 claims description 72
- 239000003242 anti bacterial agent Substances 0.000 claims description 28
- 229920000642 polymer Polymers 0.000 claims description 20
- 230000003115 biocidal effect Effects 0.000 claims description 16
- 150000001993 dienes Chemical class 0.000 claims description 7
- 229920005573 silicon-containing polymer Polymers 0.000 claims description 6
- 229920000098 polyolefin Polymers 0.000 claims description 3
- 208000019206 urinary tract infection Diseases 0.000 claims description 2
- 238000012360 testing method Methods 0.000 description 43
- 210000002700 urine Anatomy 0.000 description 39
- 238000000034 method Methods 0.000 description 38
- -1 ethylene, propylene, 1-butene Chemical class 0.000 description 28
- 229940088710 antibiotic agent Drugs 0.000 description 26
- 150000001875 compounds Chemical class 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 239000007864 aqueous solution Substances 0.000 description 18
- 230000005764 inhibitory process Effects 0.000 description 18
- 239000011248 coating agent Substances 0.000 description 17
- 238000000576 coating method Methods 0.000 description 17
- 241000894006 Bacteria Species 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 125000000524 functional group Chemical group 0.000 description 15
- 208000015181 infectious disease Diseases 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 11
- 244000043261 Hevea brasiliensis Species 0.000 description 11
- 229920003052 natural elastomer Polymers 0.000 description 11
- 229920001194 natural rubber Polymers 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
- 239000011247 coating layer Substances 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 108010093965 Polymyxin B Proteins 0.000 description 7
- JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 description 7
- 238000005342 ion exchange Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 6
- 229920002873 Polyethylenimine Polymers 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000012984 antibiotic solution Substances 0.000 description 6
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
- 125000004018 acid anhydride group Chemical group 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229920000768 polyamine Polymers 0.000 description 5
- 229920000024 polymyxin B Polymers 0.000 description 5
- 229960005266 polymyxin b Drugs 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- IEMDOFXTVAPVLX-YWQHLDGFSA-N Leucomycin A1 Chemical compound CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](N(C)C)[C@H](O[C@@H]2O[C@@H](C)[C@H](OC(=O)CC(C)C)[C@](C)(O)C2)[C@@H](C)O1 IEMDOFXTVAPVLX-YWQHLDGFSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 229940056360 penicillin g Drugs 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010078777 Colistin Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- 150000008065 acid anhydrides Chemical class 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- 229960000603 cefalotin Drugs 0.000 description 3
- VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 210000001635 urinary tract Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- DHPRQBPJLMKORJ-XRNKAMNCSA-N (4s,4as,5as,6s,12ar)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O DHPRQBPJLMKORJ-XRNKAMNCSA-N 0.000 description 2
- NALFRYPTRXKZPN-UHFFFAOYSA-N 1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane Chemical compound CC1CC(C)(C)CC(OOC(C)(C)C)(OOC(C)(C)C)C1 NALFRYPTRXKZPN-UHFFFAOYSA-N 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N 1-Heptene Chemical compound CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- QVTWQIWXCYMFQI-CZDSEFAFSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;trihydrochloride Chemical compound Cl.Cl.Cl.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O QVTWQIWXCYMFQI-CZDSEFAFSA-N 0.000 description 2
- ACTOXUHEUCPTEW-CEUOBAOPSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2r,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-CEUOBAOPSA-N 0.000 description 2
- WWUVJRULCWHUSA-UHFFFAOYSA-N 2-methyl-1-pentene Chemical compound CCCC(C)=C WWUVJRULCWHUSA-UHFFFAOYSA-N 0.000 description 2
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical class CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 108010006654 Bleomycin Proteins 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- LIRCDOVJWUGTMW-ZWNOBZJWSA-N Chloramphenicol succinate Chemical compound OC(=O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 LIRCDOVJWUGTMW-ZWNOBZJWSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010026389 Gramicidin Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 229920001744 Polyaldehyde Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- WHRVRSCEWKLAHX-LQDWTQKMSA-N benzylpenicillin procaine Chemical compound [H+].CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 WHRVRSCEWKLAHX-LQDWTQKMSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229960004244 cyclacillin Drugs 0.000 description 2
- HGBLNBBNRORJKI-WCABBAIRSA-N cyclacillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C1(N)CCCCC1 HGBLNBBNRORJKI-WCABBAIRSA-N 0.000 description 2
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 229960004905 gramicidin Drugs 0.000 description 2
- ZWCXYZRRTRDGQE-SORVKSEFSA-N gramicidina Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)CC(C)C)C(=O)NCCO)=CNC2=C1 ZWCXYZRRTRDGQE-SORVKSEFSA-N 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- SKKLOUVUUNMCJE-FQSMHNGLSA-N kanamycin B Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SKKLOUVUUNMCJE-FQSMHNGLSA-N 0.000 description 2
- 229950007634 kitasamycin Drugs 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid group Chemical group C(\C=C/C(=O)O)(=O)O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 2
- WIDKTXGNSOORHA-CJHXQPGBSA-N n,n'-dibenzylethane-1,2-diamine;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;tetrahydrate Chemical compound O.O.O.O.C=1C=CC=CC=1CNCCNCC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 WIDKTXGNSOORHA-CJHXQPGBSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadec-1-ene Chemical compound CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920001228 polyisocyanate Polymers 0.000 description 2
- 239000005056 polyisocyanate Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229960003548 polymyxin b sulfate Drugs 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- QJBZDBLBQWFTPZ-UHFFFAOYSA-N pyrrolnitrin Chemical compound [O-][N+](=O)C1=C(Cl)C=CC=C1C1=CNC=C1Cl QJBZDBLBQWFTPZ-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 229960002385 streptomycin sulfate Drugs 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tertâbutyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- ILFPCMXTASDZKM-YFKPBYRVSA-N (1s)-2-methylidene-3-oxocyclopentane-1-carboxylic acid Chemical compound OC(=O)[C@H]1CCC(=O)C1=C ILFPCMXTASDZKM-YFKPBYRVSA-N 0.000 description 1
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- ZMZWDDSEAIEIPT-LQDWTQKMSA-N (2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;pyrimidine Chemical compound C1=CN=CN=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 ZMZWDDSEAIEIPT-LQDWTQKMSA-N 0.000 description 1
- NAALWFYYHHJEFQ-ZASNTINBSA-N (2s,5r,6r)-6-[[(2r)-2-[[6-[4-[bis(2-hydroxyethyl)sulfamoyl]phenyl]-2-oxo-1h-pyridine-3-carbonyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound N([C@@H](C(=O)N[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C=1C=CC(O)=CC=1)C(=O)C(C(N1)=O)=CC=C1C1=CC=C(S(=O)(=O)N(CCO)CCO)C=C1 NAALWFYYHHJEFQ-ZASNTINBSA-N 0.000 description 1
- DZKQVWCTFCSEKF-QOEBQMAPSA-N (3r,4r)-3,6-diamino-n-[(3s,6z,9s,12s,15s)-3-[(6r)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)[C@H](O)CCN)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1.N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)[C@H](O)CCN)CNC(=O)[C@@H]1[C@@H]1NC(N)=NCC1 DZKQVWCTFCSEKF-QOEBQMAPSA-N 0.000 description 1
- NNRXCKZMQLFUPL-WBMZRJHASA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2r,3 Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 NNRXCKZMQLFUPL-WBMZRJHASA-N 0.000 description 1
- ZXBDZLHAHGPXIG-VTXLJDRKSA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2r,3 Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ZXBDZLHAHGPXIG-VTXLJDRKSA-N 0.000 description 1
- SKDGGFHGLZBNBC-YZPBMOCRSA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;dodec Chemical compound CCCCCCCCCCCCOS(O)(=O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 SKDGGFHGLZBNBC-YZPBMOCRSA-N 0.000 description 1
- RLPCJGKQKFMBEI-UOBLTHIJSA-N (3r,5s,6s,7r,8s,9r,12r,13r,14s,15r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2r,4s,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione;phosphoric a Chemical compound OP(O)(O)=O.O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RLPCJGKQKFMBEI-UOBLTHIJSA-N 0.000 description 1
- OWFJMIVZYSDULZ-PXOLEDIWSA-N (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O OWFJMIVZYSDULZ-PXOLEDIWSA-N 0.000 description 1
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- MTZUIIAIAKMWLI-UHFFFAOYSA-N 1,2-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC=C1N=C=O MTZUIIAIAKMWLI-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- PRBHEGAFLDMLAL-UHFFFAOYSA-N 1,5-Hexadiene Natural products CC=CCC=C PRBHEGAFLDMLAL-UHFFFAOYSA-N 0.000 description 1
- PGRNEGLBSNLPNP-UHFFFAOYSA-N 1,6-dichloro-3-methylhex-1-ene Chemical compound ClC=CC(C)CCCCl PGRNEGLBSNLPNP-UHFFFAOYSA-N 0.000 description 1
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- PVJKFTUUDTYJJG-UHFFFAOYSA-N 1-[2,3-di(prop-2-enoyl)triazinan-1-yl]prop-2-en-1-one Chemical compound C=CC(=O)N1CCCN(C(=O)C=C)N1C(=O)C=C PVJKFTUUDTYJJG-UHFFFAOYSA-N 0.000 description 1
- KMBSSXSNDSJXCG-UHFFFAOYSA-N 1-[2-(2-hydroxyundecylamino)ethylamino]undecan-2-ol Chemical compound CCCCCCCCCC(O)CNCCNCC(O)CCCCCCCCC KMBSSXSNDSJXCG-UHFFFAOYSA-N 0.000 description 1
- KXJGSNRAQWDDJT-UHFFFAOYSA-N 1-acetyl-5-bromo-2h-indol-3-one Chemical compound BrC1=CC=C2N(C(=O)C)CC(=O)C2=C1 KXJGSNRAQWDDJT-UHFFFAOYSA-N 0.000 description 1
- VZICYRJYXFALDQ-UHFFFAOYSA-N 1-isocyanato-6-isocyanatosulfanylhexane Chemical compound O=C=NCCCCCCSN=C=O VZICYRJYXFALDQ-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- VVJIVFKAROPUOS-UHFFFAOYSA-N 2,2-bis(aminomethyl)propane-1,3-diamine Chemical compound NCC(CN)(CN)CN VVJIVFKAROPUOS-UHFFFAOYSA-N 0.000 description 1
- HJKLEAOXCZIMPI-UHFFFAOYSA-N 2,2-diethoxyethanamine Chemical class CCOC(CN)OCC HJKLEAOXCZIMPI-UHFFFAOYSA-N 0.000 description 1
- GHKSKVKCKMGRDU-UHFFFAOYSA-N 2-(3-aminopropylamino)ethanol Chemical compound NCCCNCCO GHKSKVKCKMGRDU-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- OZDGMOYKSFPLSE-UHFFFAOYSA-N 2-Methylaziridine Chemical compound CC1CN1 OZDGMOYKSFPLSE-UHFFFAOYSA-N 0.000 description 1
- CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- LSTRKXWIZZZYAS-UHFFFAOYSA-N 2-bromoacetyl bromide Chemical compound BrCC(Br)=O LSTRKXWIZZZYAS-UHFFFAOYSA-N 0.000 description 1
- 125000005999 2-bromoethyl group Chemical group 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 1
- KGIGUEBEKRSTEW-UHFFFAOYSA-N 2-vinylpyridine Chemical compound C=CC1=CC=CC=N1 KGIGUEBEKRSTEW-UHFFFAOYSA-N 0.000 description 1
- PKXHXOTZMFCXSH-UHFFFAOYSA-N 3,3-dimethylbut-1-ene Chemical compound CC(C)(C)C=C PKXHXOTZMFCXSH-UHFFFAOYSA-N 0.000 description 1
- TUATYNXRYJTQTQ-BVRBKCERSA-N 3,6-diamino-n-[[(2s,5s,8z,11s,15s)-15-amino-11-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;3,6-diamino-n-[[(2s,5s,8z,11s,15s)-15-a Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC(=O)[C@@H]1C1NC(=N)NCC1.N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CNC(=O)CC(N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC(=O)[C@@H]1C1NC(=N)NCC1 TUATYNXRYJTQTQ-BVRBKCERSA-N 0.000 description 1
- WUIABRMSWOKTOF-OYALTWQYSA-N 3-[[2-[2-[2-[[(2s,3r)-2-[[(2s,3s,4r)-4-[[(2s,3r)-2-[[6-amino-2-[(1s)-3-amino-1-[[(2s)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2r,3s,4s,5r,6r)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)ox Chemical compound OS([O-])(=O)=O.N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1NC=NC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C WUIABRMSWOKTOF-OYALTWQYSA-N 0.000 description 1
- YHQXBTXEYZIYOV-UHFFFAOYSA-N 3-methylbut-1-ene Chemical compound CC(C)C=C YHQXBTXEYZIYOV-UHFFFAOYSA-N 0.000 description 1
- LDTAOIUHUHHCMU-UHFFFAOYSA-N 3-methylpent-1-ene Chemical compound CCC(C)C=C LDTAOIUHUHHCMU-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- PTNZGHXUZDHMIQ-UHFFFAOYSA-N 4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;hydrochloride Chemical compound Cl.C1=CC=C2C(C)C(C(O)C3C(C(O)=C(C(N)=O)C(=O)C3N(C)C)(O)C3=O)C3=C(O)C2=C1O PTNZGHXUZDHMIQ-UHFFFAOYSA-N 0.000 description 1
- YWMSSKBMOFPBDM-UHFFFAOYSA-N 4-carbamoylbenzenesulfonyl chloride Chemical compound NC(=O)C1=CC=C(S(Cl)(=O)=O)C=C1 YWMSSKBMOFPBDM-UHFFFAOYSA-N 0.000 description 1
- SUWJESCICIOQHO-UHFFFAOYSA-N 4-methylhex-1-ene Chemical compound CCC(C)CC=C SUWJESCICIOQHO-UHFFFAOYSA-N 0.000 description 1
- JIUFYGIESXPUPL-UHFFFAOYSA-N 5-methylhex-1-ene Chemical compound CC(C)CCC=C JIUFYGIESXPUPL-UHFFFAOYSA-N 0.000 description 1
- RPABDKTXMKOGKI-OYTUFZPASA-N 6-methyl-n-[2-[(2s,5s,8s,11s,14s,17s,20s,23s)-8,11,14,20-tetrakis(2-aminoethyl)-5-[(1r)-1-hydroxyethyl]-17,23-bis(2-methylpropyl)-3,6,9,12,15,18,21,24-octaoxo-1,4,7,10,13,16,19,22-octazacyclotetracos-2-yl]ethyl]octanamide Chemical compound CCC(C)CCCCC(=O)NCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H]([C@@H](C)O)NC1=O RPABDKTXMKOGKI-OYTUFZPASA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000588779 Bordetella bronchiseptica Species 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical class CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 108010065839 Capreomycin Proteins 0.000 description 1
- 229930188120 Carbomycin Natural products 0.000 description 1
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- IDWDXHQLOMJDRU-XNMGPUDCSA-N Chloramphenicol stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 IDWDXHQLOMJDRU-XNMGPUDCSA-N 0.000 description 1
- 239000004099 Chlortetracycline Substances 0.000 description 1
- GTNDZRUWKHDICY-DJHAJVGHSA-N Clindamycin palmitate hydrochloride Chemical compound Cl.O1[C@H](SC)[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@@H](O)[C@@H](O)[C@H]1[C@@H]([C@H](C)Cl)NC(=O)[C@H]1N(C)C[C@H](CCC)C1 GTNDZRUWKHDICY-DJHAJVGHSA-N 0.000 description 1
- 241000252233 Cyprinus carpio Species 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920002085 Dialdehyde starch Polymers 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- YAVZHCFFUATPRK-YZPBMOCRSA-N Erythromycin stearate Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 YAVZHCFFUATPRK-YZPBMOCRSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- AGJUUQSLGVCRQA-SWOUQTJZSA-N Fungichromin Chemical compound CCCCC[C@@H](O)[C@@H]1[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)C[C@@H](O)[C@@H](O)[C@H](O)\C(C)=C\C=C\C=C\C=C\C=C\[C@H](O)[C@@H](C)OC1=O AGJUUQSLGVCRQA-SWOUQTJZSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000042215 Leucochloridiomorpha lutea Species 0.000 description 1
- 229930184158 Maridomycin Natural products 0.000 description 1
- VZQARNDJLLWXGL-CCHMMTNSSA-N Methacycline hydrochloride Chemical compound Cl.C=C([C@H]1[C@@H]2O)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O VZQARNDJLLWXGL-CCHMMTNSSA-N 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- DMUAPQTXSSNEDD-QALJCMCCSA-N Midecamycin Chemical compound C1[C@](O)(C)[C@@H](OC(=O)CC)[C@H](C)O[C@H]1O[C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC(=O)CC)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@@H]2CC=O)OC)O[C@@H]1C DMUAPQTXSSNEDD-QALJCMCCSA-N 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- VIWZVFVJPXTXPA-UHFFFAOYSA-N N-(2-Carboxymethyl)-morpholine Chemical compound OC(=O)CN1CCOCC1 VIWZVFVJPXTXPA-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 101710204212 Neocarzinostatin Proteins 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- XWBRONCZROYZRL-UHFFFAOYSA-N O1CCN(CC1)CC(=O)O.S(=O)(=O)(O)O Chemical compound O1CCN(CC1)CC(=O)O.S(=O)(=O)(O)O XWBRONCZROYZRL-UHFFFAOYSA-N 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930195708 Penicillin V Natural products 0.000 description 1
- AGJUUQSLGVCRQA-UHFFFAOYSA-N Pentamycin Natural products CCCCCC(O)C1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)C(O)C(O)C(C)=CC=CC=CC=CC=CC(O)C(C)OC1=O AGJUUQSLGVCRQA-UHFFFAOYSA-N 0.000 description 1
- NCXMLFZGDNKEPB-UHFFFAOYSA-N Pimaricin Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCC(C)OC(=O)C=CC2OC2CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 NCXMLFZGDNKEPB-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 241000192023 Sarcina Species 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 241000751182 Staphylococcus epidermidis ATCC 12228 Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- ZYPGADGCNXOUJP-CXVPHVKISA-N Variotin Chemical compound CCCC[C@@H](O)\C=C(/C)\C=C\C=C\C(=O)N1CCCC1=O ZYPGADGCNXOUJP-CXVPHVKISA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- FFXJTOKFQATYBI-RUTGJBPVSA-N [(1s,3r,7r,8s,9s,10r,12r,13r,14e,16s)-9-[(2s,3r,4r,5s,6r)-4-(dimethylamino)-3-hydroxy-5-[(2s,4r,5s,6s)-4-hydroxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-13-hydroxy-8-methoxy-3,12-dimethyl-5-oxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1 Chemical compound C1[C@](O)(C)[C@@H](OC(=O)CC)[C@H](C)O[C@H]1O[C@H]1[C@H](N(C)C)[C@@H](O)[C@H](O[C@@H]2[C@H]([C@H](OC(=O)CC)CC(=O)O[C@H](C)C[C@@H]3O[C@H]3/C=C/[C@H](O)[C@H](C)C[C@@H]2CC=O)OC)O[C@@H]1C FFXJTOKFQATYBI-RUTGJBPVSA-N 0.000 description 1
- BSUQCLSFQSUNED-PPPRQHODSA-N [(2s,3r,4s,6r)-4-(dimethylamino)-2-[[(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] ethyl car Chemical compound O1[C@H](C)C[C@H](N(C)C)[C@@H](OC(=O)OCC)[C@@H]1O[C@H]1[C@@](O)(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(OC)C2)[C@@H]1C BSUQCLSFQSUNED-PPPRQHODSA-N 0.000 description 1
- FQVHOULQCKDUCY-OGHXVOSASA-N [(2s,3s,4r,6s)-6-[(2r,3s,4r,5r,6s)-6-[[(1s,3r,7r,8s,9s,10r,12r,14e,16s)-7-acetyloxy-8-methoxy-3,12-dimethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimeth Chemical compound O([C@@H]1[C@@H](C)O[C@H]([C@@H]([C@H]1N(C)C)O)O[C@H]1[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/[C@@H]2O[C@H]2C[C@@H](C)OC(=O)C[C@H]([C@@H]1OC)OC(C)=O)[C@H]1C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O1 FQVHOULQCKDUCY-OGHXVOSASA-N 0.000 description 1
- GKXVJHDEWHKBFH-UHFFFAOYSA-N [2-(aminomethyl)phenyl]methanamine Chemical compound NCC1=CC=CC=C1CN GKXVJHDEWHKBFH-UHFFFAOYSA-N 0.000 description 1
- QEFDFGVDVZTFAK-GGXMVOPNSA-N [2-[(2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-2-oxoethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 QEFDFGVDVZTFAK-GGXMVOPNSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Chemical class CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229960001656 amikacin sulfate Drugs 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- IMUDHTPIFIBORV-UHFFFAOYSA-N aminoethylpiperazine Chemical compound NCCN1CCNCC1 IMUDHTPIFIBORV-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- JOSWYUNQBRPBDN-UHFFFAOYSA-P ammonium dichromate Chemical compound [NH4+].[NH4+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O JOSWYUNQBRPBDN-UHFFFAOYSA-P 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- 229960001931 ampicillin sodium Drugs 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- UGZYFXMSMFMTSM-UHFFFAOYSA-N aureothricin Chemical compound S1SC=C2N(C)C(=O)C(NC(=O)CC)=C21 UGZYFXMSMFMTSM-UHFFFAOYSA-N 0.000 description 1
- WAYBAXDAQZLSTG-UHFFFAOYSA-N aureothricin Natural products CCC(=O)NC1C2SSC=C2NC1=O WAYBAXDAQZLSTG-UHFFFAOYSA-N 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229960001192 bekanamycin Drugs 0.000 description 1
- IZALUMVGBVKPJD-UHFFFAOYSA-N benzene-1,3-dicarbaldehyde Chemical compound O=CC1=CC=CC(C=O)=C1 IZALUMVGBVKPJD-UHFFFAOYSA-N 0.000 description 1
- FDQSRULYDNDXQB-UHFFFAOYSA-N benzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC(C(Cl)=O)=C1 FDQSRULYDNDXQB-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940053013 bio-mycin Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 229960004395 bleomycin sulfate Drugs 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- RGTXVXDNHPWPHH-UHFFFAOYSA-N butane-1,3-diamine Chemical compound CC(N)CCN RGTXVXDNHPWPHH-UHFFFAOYSA-N 0.000 description 1
- GHWVXCQZPNWFRO-UHFFFAOYSA-N butane-2,3-diamine Chemical compound CC(N)C(C)N GHWVXCQZPNWFRO-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- NPTZOUGIOYWQFI-ANPZCEIESA-L calcium;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound [Ca+2].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 NPTZOUGIOYWQFI-ANPZCEIESA-L 0.000 description 1
- VANYVCHXDYVKSI-MXWBXKMOSA-L calcium;(6ar,10s,10ar,11s,11ar,12s)-8-carbamoyl-10-(dimethylamino)-4,6a,7,11,12-pentahydroxy-12-methyl-6,9-dioxo-10,10a,11,11a-tetrahydrotetracen-5-olate Chemical compound [Ca+2].C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C([O-])C2=C1O.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C([O-])C2=C1O VANYVCHXDYVKSI-MXWBXKMOSA-L 0.000 description 1
- HEJBMFPJLCJWER-CWPVBXIBSA-L calcium;7-[(2r,3r,4s,5r)-4-carbamoyloxy-3-hydroxy-5-methoxy-6,6-dimethyloxan-2-yl]oxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-4-olate Chemical compound [Ca+2].O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C([O-])=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C.O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C([O-])=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C HEJBMFPJLCJWER-CWPVBXIBSA-L 0.000 description 1
- 229960002968 capreomycin sulfate Drugs 0.000 description 1
- 229960004304 carbenicillin phenyl sodium Drugs 0.000 description 1
- 229950005779 carbomycin Drugs 0.000 description 1
- NZDASSHFKWDBBU-KVMCETHSSA-N carfecillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C=1C=CC=CC=1)C(=O)OC1=CC=CC=C1 NZDASSHFKWDBBU-KVMCETHSSA-N 0.000 description 1
- 229960003866 cefaloridine Drugs 0.000 description 1
- CZTQZXZIADLWOZ-CRAIPNDOSA-N cefaloridine Chemical compound O=C([C@@H](NC(=O)CC=1SC=CC=1)[C@H]1SC2)N1C(C(=O)[O-])=C2C[N+]1=CC=CC=C1 CZTQZXZIADLWOZ-CRAIPNDOSA-N 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- 229960004366 ceftezole Drugs 0.000 description 1
- DZMVCVMFETWNIU-LDYMZIIASA-N ceftezole Chemical compound O=C([C@@H](NC(=O)CN1N=NN=C1)[C@H]1SC2)N1C(C(=O)O)=C2CSC1=NN=CS1 DZMVCVMFETWNIU-LDYMZIIASA-N 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 229920006218 cellulose propionate Polymers 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- VGEOUKPOQQEQSX-OALZAMAHSA-M cephapirin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CSC1=CC=NC=C1 VGEOUKPOQQEQSX-OALZAMAHSA-M 0.000 description 1
- XMEVHPAGJVLHIG-FMZCEJRJSA-N chembl454950 Chemical compound [Cl-].C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H]([NH+](C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O XMEVHPAGJVLHIG-FMZCEJRJSA-N 0.000 description 1
- 229960001805 chloramphenicol palmitate Drugs 0.000 description 1
- PXKHGMGELZGJQE-ILBGXUMGSA-N chloramphenicol palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 PXKHGMGELZGJQE-ILBGXUMGSA-N 0.000 description 1
- 229960002579 chloramphenicol sodium succinate Drugs 0.000 description 1
- 229960003363 chloramphenicol stearate Drugs 0.000 description 1
- 229960004357 chloramphenicol succinate Drugs 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 description 1
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960001200 clindamycin hydrochloride Drugs 0.000 description 1
- 229960000792 clindamycin palmitate hydrochloride Drugs 0.000 description 1
- 229960003026 cloxacillin sodium Drugs 0.000 description 1
- SCLZRKVZRBKZCR-SLINCCQESA-M cloxacillin sodium Chemical compound [Na+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl SCLZRKVZRBKZCR-SLINCCQESA-M 0.000 description 1
- 229960003346 colistin Drugs 0.000 description 1
- 229960001127 colistin sulfate Drugs 0.000 description 1
- 108700028201 colistinmethanesulfonic acid Proteins 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- CFBGXYDUODCMNS-UHFFFAOYSA-N cyclobutene Chemical compound C1CC=C1 CFBGXYDUODCMNS-UHFFFAOYSA-N 0.000 description 1
- PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical compound OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 description 1
- 229960003077 cycloserine Drugs 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 229960003109 daunorubicin hydrochloride Drugs 0.000 description 1
- YQLZOAVZWJBZSY-UHFFFAOYSA-N decane-1,10-diamine Chemical compound NCCCCCCCCCCN YQLZOAVZWJBZSY-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 229960004060 dicloxacillin sodium Drugs 0.000 description 1
- SIGZQNJITOWQEF-VICXVTCVSA-M dicloxacillin sodium monohydrate Chemical compound O.[Na+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=C(Cl)C=CC=C1Cl SIGZQNJITOWQEF-VICXVTCVSA-M 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229960001162 dihydrostreptomycin sulfate Drugs 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- FWRNIJIOFYDBES-ZQDFAFASSA-L disodium;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[[(2r)-2-phenyl-2-sulfonatoacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound [Na+].[Na+].C1([C@H](C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)S([O-])(=O)=O)=CC=CC=C1 FWRNIJIOFYDBES-ZQDFAFASSA-L 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- ZYPGADGCNXOUJP-UHFFFAOYSA-N dl-Variotin Natural products CCCCC(O)C=C(C)C=CC=CC(=O)N1CCCC1=O ZYPGADGCNXOUJP-UHFFFAOYSA-N 0.000 description 1
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 1
- 229960002918 doxorubicin hydrochloride Drugs 0.000 description 1
- 229960004082 doxycycline hydrochloride Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 208000005053 encephalomalacia Diseases 0.000 description 1
- NJCUSQKMYNTYOW-MWUYRYRWSA-N enramicina Chemical compound O.N1C(=O)NC(=O)C(C=2C=C(Cl)C(O)=C(Cl)C=2)NC(=O)C(CO)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(CC2N=C(N)NC2)NC(=O)C(CCCNC(N)=O)NC(=O)C(C(C)O)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C(C)O)NC(=O)N(CCCCN)C(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)/C=C/C=C/CCCCC(C)CC)C(C)OC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C)NC(=O)C1CC1CNC(N)=N1 NJCUSQKMYNTYOW-MWUYRYRWSA-N 0.000 description 1
- 229950003984 enramycin Drugs 0.000 description 1
- 108700041171 enramycin Proteins 0.000 description 1
- 229950000219 enviomycin Drugs 0.000 description 1
- NSYZCCDSJNWWJL-YXOIYICCSA-N erythromycin ethylsuccinate Chemical compound O1[C@H](C)C[C@H](N(C)C)[C@@H](OC(=O)CCC(=O)OCC)[C@@H]1O[C@H]1[C@@](O)(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(OC)C2)[C@@H]1C NSYZCCDSJNWWJL-YXOIYICCSA-N 0.000 description 1
- 229960000741 erythromycin ethylsuccinate Drugs 0.000 description 1
- 229960004213 erythromycin lactobionate Drugs 0.000 description 1
- 229960004142 erythromycin stearate Drugs 0.000 description 1
- YYXLGGIKSIZHSF-UHFFFAOYSA-N ethene;furan-2,5-dione Chemical group C=C.O=C1OC(=O)C=C1 YYXLGGIKSIZHSF-UHFFFAOYSA-N 0.000 description 1
- LDLDYFCCDKENPD-UHFFFAOYSA-N ethenylcyclohexane Chemical compound C=CC1CCCCC1 LDLDYFCCDKENPD-UHFFFAOYSA-N 0.000 description 1
- YIWFBNMYFYINAD-UHFFFAOYSA-N ethenylcyclopropane Chemical compound C=CC1CC1 YIWFBNMYFYINAD-UHFFFAOYSA-N 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229960004273 floxacillin Drugs 0.000 description 1
- PARMJFIQRZRMHG-VICXVTCVSA-M flucloxacillin sodium monohydrate Chemical compound O.[Na+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl PARMJFIQRZRMHG-VICXVTCVSA-M 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- GEAWFZNTIFJMHR-UHFFFAOYSA-N hepta-1,6-diene Chemical compound C=CCCCC=C GEAWFZNTIFJMHR-UHFFFAOYSA-N 0.000 description 1
- QRSPJBLLJXVPDD-XFAPPKAWSA-M hetacillin potassium Chemical compound [K+].C1([C@@H]2C(=O)N(C(N2)(C)C)[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 QRSPJBLLJXVPDD-XFAPPKAWSA-M 0.000 description 1
- 229960002041 hetacillin potassium Drugs 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical compound C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- CFUQBFQTFMOZBK-QUCCMNQESA-N ibazocine Chemical compound C12=CC(O)=CC=C2C[C@H]2N(CC=C(C)C)CC[C@]1(C)C2(C)C CFUQBFQTFMOZBK-QUCCMNQESA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- NPURPEXKKDAKIH-UHFFFAOYSA-N iodoimino(oxo)methane Chemical group IN=C=O NPURPEXKKDAKIH-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 229960001595 lincomycin hydrochloride Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229960004196 lymecycline Drugs 0.000 description 1
- AHEVKYYGXVEWNO-UEPZRUIBSA-N lymecycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(=O)NCNCCCC[C@H](N)C(O)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O AHEVKYYGXVEWNO-UEPZRUIBSA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229950002784 maridomycin Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229940051860 methacycline hydrochloride Drugs 0.000 description 1
- 229940019826 methicillin sodium Drugs 0.000 description 1
- MGFZNWDWOKASQZ-UMLIZJHQSA-M methicillin sodium Chemical compound [Na+].COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 MGFZNWDWOKASQZ-UMLIZJHQSA-M 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229960002757 midecamycin Drugs 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- KYCGURZGBKFEQB-UHFFFAOYSA-N n',n'-dibutylpropane-1,3-diamine Chemical compound CCCCN(CCCC)CCCN KYCGURZGBKFEQB-UHFFFAOYSA-N 0.000 description 1
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- ZUXUNWLVIWKEHB-UHFFFAOYSA-N n',n'-dimethylhexane-1,6-diamine Chemical compound CN(C)CCCCCCN ZUXUNWLVIWKEHB-UHFFFAOYSA-N 0.000 description 1
- KMBPCQSCMCEPMU-UHFFFAOYSA-N n'-(3-aminopropyl)-n'-methylpropane-1,3-diamine Chemical compound NCCCN(C)CCCN KMBPCQSCMCEPMU-UHFFFAOYSA-N 0.000 description 1
- IMENJLNZKOMSMC-UHFFFAOYSA-N n'-[2-[2-[2-[2-[2-(2-aminoethylamino)ethylamino]ethylamino]ethylamino]ethylamino]ethyl]ethane-1,2-diamine Chemical compound NCCNCCNCCNCCNCCNCCNCCN IMENJLNZKOMSMC-UHFFFAOYSA-N 0.000 description 1
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 description 1
- HDCAZTXEZQWTIJ-UHFFFAOYSA-N n,n',n'-triethylethane-1,2-diamine Chemical compound CCNCCN(CC)CC HDCAZTXEZQWTIJ-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 1
- ZESIAEVDVPWEKB-ORCFLVBFSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O ZESIAEVDVPWEKB-ORCFLVBFSA-N 0.000 description 1
- PZMRMZQWGOESGV-UHFFFAOYSA-N n-ethyl-2-ethyliminoethanamine Chemical compound CCNCC=NCC PZMRMZQWGOESGV-UHFFFAOYSA-N 0.000 description 1
- HALVJFMEOOBLMQ-UHFFFAOYSA-N n-ethyl-2-methyliminoethanamine Chemical compound CCNCC=NC HALVJFMEOOBLMQ-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960003255 natamycin Drugs 0.000 description 1
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- QZGIWPZCWHMVQL-UIYAJPBUSA-N neocarzinostatin chromophore Chemical compound O1[C@H](C)[C@H](O)[C@H](O)[C@@H](NC)[C@H]1O[C@@H]1C/2=C/C#C[C@H]3O[C@@]3([C@@H]3OC(=O)OC3)C#CC\2=C[C@H]1OC(=O)C1=C(O)C=CC2=C(C)C=C(OC)C=C12 QZGIWPZCWHMVQL-UIYAJPBUSA-N 0.000 description 1
- OIXVKQDWLFHVGR-WQDIDPJDSA-N neomycin B sulfate Chemical compound OS(O)(=O)=O.N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO OIXVKQDWLFHVGR-WQDIDPJDSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- SXJVFQLYZSNZBT-UHFFFAOYSA-N nonane-1,9-diamine Chemical compound NCCCCCCCCCN SXJVFQLYZSNZBT-UHFFFAOYSA-N 0.000 description 1
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- 229960004781 novobiocin sodium Drugs 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-M novobiocin(1-) Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C([O-])=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-M 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002351 oleandomycin Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229960003994 oxacillin sodium Drugs 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- BSCHIACBONPEOB-UHFFFAOYSA-N oxolane;hydrate Chemical compound O.C1CCOC1 BSCHIACBONPEOB-UHFFFAOYSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 229960004548 oxytetracycline calcium Drugs 0.000 description 1
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229960005065 paromomycin sulfate Drugs 0.000 description 1
- 229940056367 penicillin v Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 229960000339 pentamycin Drugs 0.000 description 1
- JGQDLMSXMOGEMC-UHFFFAOYSA-N pentane-2,4-diamine Chemical compound CC(N)CC(C)N JGQDLMSXMOGEMC-UHFFFAOYSA-N 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- ORMNNUPLFAPCFD-DVLYDCSHSA-M phenethicillin potassium Chemical compound [K+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C(C)OC1=CC=CC=C1 ORMNNUPLFAPCFD-DVLYDCSHSA-M 0.000 description 1
- BPLBGHOLXOTWMN-MBNYWOFBSA-N phenoxymethylpenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)COC1=CC=CC=C1 BPLBGHOLXOTWMN-MBNYWOFBSA-N 0.000 description 1
- BBTOYUUSUQNIIY-ANPZCEIESA-N phenoxymethylpenicillin benzathine Chemical compound C=1C=CC=CC=1C[NH2+]CC[NH2+]CC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 BBTOYUUSUQNIIY-ANPZCEIESA-N 0.000 description 1
- HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- LRWJZGCOPMDWFZ-UHFFFAOYSA-N phthalic acid;hydrochloride Chemical compound Cl.OC(=O)C1=CC=CC=C1C(O)=O LRWJZGCOPMDWFZ-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- PMJHHCWVYXUKFD-UHFFFAOYSA-N piperylene Natural products CC=CC=C PMJHHCWVYXUKFD-UHFFFAOYSA-N 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920003192 poly(bis maleimide) Polymers 0.000 description 1
- 229920000141 poly(maleic anhydride) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 1
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- ULBKMFLWMIGVOJ-CFXUUZMDSA-M propicillin potassium Chemical compound [K+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C(CC)OC1=CC=CC=C1 ULBKMFLWMIGVOJ-CFXUUZMDSA-M 0.000 description 1
- 229960005482 propicillin potassium Drugs 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 201000004537 pyelitis Diseases 0.000 description 1
- 229960002132 pyrrolnitrin Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 229920002631 room-temperature vulcanizate silicone Polymers 0.000 description 1
- 150000003839 salts Chemical group 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- ILFPCMXTASDZKM-UHFFFAOYSA-N sarkomycin Natural products OC(=O)C1CCC(=O)C1=C ILFPCMXTASDZKM-UHFFFAOYSA-N 0.000 description 1
- ORVLUIMCZUPAPB-LBTQIPEASA-M sodium (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide dioxido(oxo)phosphanium phosphenic acid Chemical compound [Na+].O[P+]([O-])=O.O[P+]([O-])=O.O[P+]([O-])=O.O[P+]([O-])=O.O[P+]([O-])=O.[O-][P+]([O-])=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O.CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)c4c(O)cccc4[C@@]3(C)O)C(=O)[C@]2(O)C(O)=C(C(N)=O)C1=O ORVLUIMCZUPAPB-LBTQIPEASA-M 0.000 description 1
- FDRCDNZGSXJAFP-UHFFFAOYSA-M sodium chloroacetate Chemical compound [Na+].[O-]C(=O)CCl FDRCDNZGSXJAFP-UHFFFAOYSA-M 0.000 description 1
- VDUVBBMAXXHEQP-ZTRPPZFVSA-M sodium;(2s,6r)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate Chemical compound [Na+].N([C@@H]1C(N2[C@H](C(C)(C)SC21)C([O-])=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1 VDUVBBMAXXHEQP-ZTRPPZFVSA-M 0.000 description 1
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229960000887 spectinomycin hydrochloride Drugs 0.000 description 1
- DCHJOVNPPSBWHK-UXXUFHFZSA-N spectinomycin hydrochloride hydrate Chemical compound O.O.O.O.O.Cl.Cl.O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O DCHJOVNPPSBWHK-UXXUFHFZSA-N 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 229950006796 spiramycin ii Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012612 static experiment Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000008054 sulfonate salts Chemical class 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229960004989 tetracycline hydrochloride Drugs 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229930188428 trichomycin Natural products 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 1
- LQCLVBQBTUVCEQ-QTFUVMRISA-N troleandomycin Chemical compound O1[C@@H](C)[C@H](OC(C)=O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](OC(C)=O)[C@@H](C)C(=O)[C@@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(C)=O)[C@H]1C LQCLVBQBTUVCEQ-QTFUVMRISA-N 0.000 description 1
- 229960005041 troleandomycin Drugs 0.000 description 1
- KLNPWTHGTVSSEU-UHFFFAOYSA-N undecane-1,11-diamine Chemical compound NCCCCCCCCCCCN KLNPWTHGTVSSEU-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229950009268 zinostatin Drugs 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ããªã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»
éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæ
ãããå°å°¿ã«ããŒãã«ã®æ¹è¯ã«é¢ãããã®ã§ã
ãã
éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæ
ãããå°å°¿ã«ããŒãã«ã®æ¹è¯ã«é¢ãããã®ã§ã
ãã
èé«æå·ïŒè³åºè¡ïŒè³è»åçïŒæè¡åŸã®æ£è
ã«
ãããŠã¯æå°¿å°é£ïŒå°¿å€±çŠãªã©ã®çç¶ã䌎ãããš
ãå€ãããã®ãããªå Žåã«ã¯ãåæ»ãªå°¿è·¯ã確ä¿
ãããã®çµæãè æ©èœã®ç¶æãæ¹åãä¿ãããã
ãã¯å°¿ã®æŒåºãé²æ¢ãããšãã€ãæå³ã§ã«ããŒã
ã«ãçšããå°å°¿æ³ãæ¡çšãããããã®éã«çšãã
ããã«ããŒãã«ã¯ç¹ã«å°å°¿ã«ããŒãã«ãšç§°ããã
ãã®çšéäžããå åãªæè»æ§ïŒåŒŸåæ§ããã³äººäœ
ç¡å®³æ§ãæããããšãå¿ èŠã§ãããã»ãšãã©ã¯ãª
ã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»éåäœãŸãã¯ã·
ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæãããŠããã
ãããŠã¯æå°¿å°é£ïŒå°¿å€±çŠãªã©ã®çç¶ã䌎ãããš
ãå€ãããã®ãããªå Žåã«ã¯ãåæ»ãªå°¿è·¯ã確ä¿
ãããã®çµæãè æ©èœã®ç¶æãæ¹åãä¿ãããã
ãã¯å°¿ã®æŒåºãé²æ¢ãããšãã€ãæå³ã§ã«ããŒã
ã«ãçšããå°å°¿æ³ãæ¡çšãããããã®éã«çšãã
ããã«ããŒãã«ã¯ç¹ã«å°å°¿ã«ããŒãã«ãšç§°ããã
ãã®çšéäžããå åãªæè»æ§ïŒåŒŸåæ§ããã³äººäœ
ç¡å®³æ§ãæããããšãå¿ èŠã§ãããã»ãšãã©ã¯ãª
ã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»éåäœãŸãã¯ã·
ãªã³ã³ç³»éåäœãçŽ æãšããŠäœæãããŠããã
å°å°¿æ³ã¯æå°¿ãéããã«è¡ããããšãã€ã極ã
ãŠæçšãªæ²»çæ段ã§ããããæ³å°¿åšç§ã®ã¿ãªã
ããå€ç§ïŒå ç§ïŒç£å©Šäººç§ãªã©ã®é åã§æ¥åžžçã«
ç¹çšãããŠããããäžæ¹ã§ã¯ããã€ããå°å°¿ã«ã
ãŒãã«ãå°¿è·¯ã«ç眮ããããšææã®çºçã¯é¿ãé£
ããšããåé¡ããããããªãã¡ãå°å°¿ã«ããŒãã«
ã¯é·æéå°¿è·¯ã«ç眮ããŠãããã®ã§ãããããã
ã®ã«ããŒãã«ãéããŠçŽ°èãäŸµå ¥ããå°¿éçïŒè
è±çïŒè ççãªã©ã®çç¶ãé »çºãããåŸæ¥ããå€
çšãããŠããéæŸæç¶å°å°¿æ³ïŒç¡åç¶ãªã©æ» èã
ããŠããªã容åšã«éå°¿ããæ¹æ³ïŒãæœè¡ããå Žå
ã«ã¯ãïŒæ¥ä»¥å ã«42ã80ïŒ ã®çäŸã«ææãçºç
ããïŒæ¥ç®ã«ã¯å šäŸã«ææãæç«ããããšãå ±å
ãããŠããã
ãŠæçšãªæ²»çæ段ã§ããããæ³å°¿åšç§ã®ã¿ãªã
ããå€ç§ïŒå ç§ïŒç£å©Šäººç§ãªã©ã®é åã§æ¥åžžçã«
ç¹çšãããŠããããäžæ¹ã§ã¯ããã€ããå°å°¿ã«ã
ãŒãã«ãå°¿è·¯ã«ç眮ããããšææã®çºçã¯é¿ãé£
ããšããåé¡ããããããªãã¡ãå°å°¿ã«ããŒãã«
ã¯é·æéå°¿è·¯ã«ç眮ããŠãããã®ã§ãããããã
ã®ã«ããŒãã«ãéããŠçŽ°èãäŸµå ¥ããå°¿éçïŒè
è±çïŒè ççãªã©ã®çç¶ãé »çºãããåŸæ¥ããå€
çšãããŠããéæŸæç¶å°å°¿æ³ïŒç¡åç¶ãªã©æ» èã
ããŠããªã容åšã«éå°¿ããæ¹æ³ïŒãæœè¡ããå Žå
ã«ã¯ãïŒæ¥ä»¥å ã«42ã80ïŒ ã®çäŸã«ææãçºç
ããïŒæ¥ç®ã«ã¯å šäŸã«ææãæç«ããããšãå ±å
ãããŠããã
ãã®ããå°¿è·¯ææé²æ¢ã«é¢ããŠã¯èè±ã®æŽæµã
殺èå€ã®æ³šå ¥ãªã©ã®æ¹æ³ãè¡ãããŠããããæäœ
ãé¢åã§ããããŸããã®æäœãè¡ãããšèªäœãæ°
ããªæææºãšãªããšãã€ãäžéœåãªé¢ãå€ãã
殺èå€ã®æ³šå ¥ãªã©ã®æ¹æ³ãè¡ãããŠããããæäœ
ãé¢åã§ããããŸããã®æäœãè¡ãããšèªäœãæ°
ããªæææºãšãªããšãã€ãäžéœåãªé¢ãå€ãã
ãŸããæçç©è³ªã®äºé²çæäžãªã©ã®ååŠçæ³ã
è¡ãããŠãããã倧éæäžãããã¯æçç©è³ªã®çš®
é¡ã«ãã€ãŠã¯å°éã«ãŠãé »çºããå¯äœçšã®åé¡ã
ãã³äžããææãçãããšè亀代çãçºçŸããã
ãããšãªã©ã®åé¡ããç¡èšç»ãªååŠçæ³ã¯ããã
æ害ã§ãããšèšãããçšã«æçç©è³ªã«é¢ããŠã¯å±
æçå©çšã匷ãæãŸããŠããã
è¡ãããŠãããã倧éæäžãããã¯æçç©è³ªã®çš®
é¡ã«ãã€ãŠã¯å°éã«ãŠãé »çºããå¯äœçšã®åé¡ã
ãã³äžããææãçãããšè亀代çãçºçŸããã
ãããšãªã©ã®åé¡ããç¡èšç»ãªååŠçæ³ã¯ããã
æ害ã§ãããšèšãããçšã«æçç©è³ªã«é¢ããŠã¯å±
æçå©çšã匷ãæãŸããŠããã
æçç©è³ªã®å±æçå©çšã«é¢ããŠã¯ãå°å°¿ã«ããŒ
ãã«ã«æçç©è³ªå ¥ãã®è»èãå¡åžããããå£é¢ã«
æš¹èãã³ãŒãã€ã³ã°ããã®ã³ãŒãã€ã³ã°å±€ã«æç
ç©è³ªãå«ãŸããŠäœ¿çšãããšãã€ãæ¹æ³ïŒç¹å ¬æ54
â27680å·ïŒãææ¡ãããŠãããããããã®æ¹æ³
ã«ããå Žåãæçç©è³ªã¯æ¯æå±€ã«åžçãããŠãã
ã ãã§ãããããäœå ç眮åŸæ¥µããŠçæéã«æç
ç©è³ªã¯å°¿ã«ãã€ãŠæŽãæµããäœå€ã«æµåºããæè
æ©èœãèªããããªããªãããšããæºè¶³ã«äœ¿çšãã
ããã®ã§ã¯ãªãã
ãã«ã«æçç©è³ªå ¥ãã®è»èãå¡åžããããå£é¢ã«
æš¹èãã³ãŒãã€ã³ã°ããã®ã³ãŒãã€ã³ã°å±€ã«æç
ç©è³ªãå«ãŸããŠäœ¿çšãããšãã€ãæ¹æ³ïŒç¹å ¬æ54
â27680å·ïŒãææ¡ãããŠãããããããã®æ¹æ³
ã«ããå Žåãæçç©è³ªã¯æ¯æå±€ã«åžçãããŠãã
ã ãã§ãããããäœå ç眮åŸæ¥µããŠçæéã«æç
ç©è³ªã¯å°¿ã«ãã€ãŠæŽãæµããäœå€ã«æµåºããæè
æ©èœãèªããããªããªãããšããæºè¶³ã«äœ¿çšãã
ããã®ã§ã¯ãªãã
ãŸããã¹ãªãŒãŠãšã€ã«ããŒãã«ãšåŒã°ãããã®
ãçšããŠæçç©è³ªåžé溶液ãèè±å ã«çŽæ¥ç¹æ»Žã
ãæ¹æ³ãªã©ãå±æçæ²»çæ³ãšããŠãšãããŠãã
ããåæ±ããå°é£ã§é¢åãªãããäžéšã®æ³å°¿åšç§
ã§æ¡çšãããŠããã«ããããä»ã®èšåºé åã§ã¯çš
ããããŠããªãã®ãçŸç¶ã§ããã
ãçšããŠæçç©è³ªåžé溶液ãèè±å ã«çŽæ¥ç¹æ»Žã
ãæ¹æ³ãªã©ãå±æçæ²»çæ³ãšããŠãšãããŠãã
ããåæ±ããå°é£ã§é¢åãªãããäžéšã®æ³å°¿åšç§
ã§æ¡çšãããŠããã«ããããä»ã®èšåºé åã§ã¯çš
ããããŠããªãã®ãçŸç¶ã§ããã
现èã®äŸµå
¥çµè·¯ãšããŠã¯å°å°¿ã«ããŒãã«ãšå°¿
è·¯ç²èã®ééãéè¡ïŒç®¡å€æ§çµè·¯ïŒïŒå°å°¿ã«ã
ãŒãã«ãšå°ç®¡ãšã®çµåéšããã®äŸµå ¥ïŒæŽæµãªã©ã®
åŠçœ®ãå«ãïŒïŒèå°¿éšããå°ç®¡ããã³å°å°¿ã«ã
ãŒãã«å éšã®éè¡ïŒç®¡å æ§çµè·¯ïŒãããã管å€æ§
çµè·¯ããã®äŸµå ¥ã«ãŠã¯å°¿éåžžåšèãç眮åŸæ©æã«
ã¯å°å°¿ã«ããŒãã«ã®å£ãäŒã€ãŠéããã«äžè¡ãã
èè±é éšã«éããããã®ãããªææã«å¯ŸããŠã¯å°
å°¿ã«ããŒãã«ã®å£é¢ã«ååšããæçç©è³ªã¯çŽæ¥è
ãšæ¥ããããšãã§ããã®ã§æèæ©èœãçºæ®ãåŸ
ããããããªãã管å æ§çµè·¯ïŒäŸãã°éå°¿åšãã
ã®äŸµå ¥ïŒããªãã¡éå°¿åšã«èœäžãããã¯äŸµå ¥ãã
现èã¯ã貯çããŠããå°¿äžã§å¢æ®ããå°¿ã®éæµã
æ°æ³¡ã®äžæã«äŒŽã€ãŠèè±å ã«ãŸã§éãããå®éã
é眮å®éšã«ãããŠãé¯ã®æ»æãã®ããšãã«çŽ°èã
å°¿äžãé¡ãããšã確èªãããŠããããã®ãããªçµ
è·¯ããã®äŸµå ¥ã«å¯ŸããŠã¯ãå°å°¿ã«ããŒãã«ã®å£é¢
ã«ååšããæçç©è³ªã¯èãšçŽæ¥æ¥ããããšãã§ã
ãªãããšãèµ·ããåŸããããæèæ©èœã®åã°ãªã
èãæ®åããå¯èœæ§ãé«ããææé²æ¢èœåã¯å å
ã§ã¯ãªããå šãŠã®äŸµå ¥çµè·¯ããã®ææã«å¯ŸããŠé²
æ¢èœåãæã€ããã«ã¯ãæçç©è³ªã¯å°å°¿ã«ããŒã
ã«ã®å£é¢ã«ååšããã ãã§ãªããåŸã ã«å£é¢ãã
é¢ããŠå°¿äžã«æ¡æ£ããŠãããå°¿å ãæµ®éäžåãã
现èã«æ¥ããããšãå¿ èŠã§ããããã®å Žåãæç
ç©è³ªãå£é¢ããé¢ããŠããéã®é床ãåé¡ãšãª
ããåè¿°ã®ããšãå°å°¿ã«ããŒãã«ã«æçç©è³ªãåž
çãããããæçç©è³ªå ¥ãã®è»èãå¡åžãããã
ããã¯å£é¢ã«æš¹èãã³ãŒãã€ã³ã°ãããã®ã³ãŒã
ã€ã³ã°å±€ã«æçç©è³ªãå«ãŸããŠäœ¿çšãããããšã
æ¹æ³ãå®æœããå Žåã«ã¯ãæçç©è³ªã¯å°¿ã«ãã€ãŠ
ç°¡åã«æŽãæµããäœå€ã«æµåºãã極ããŠçæéã«
ãŠå£é¢ã«ãå°¿äžã«ãååšããªããªãããã®ããšã¯
極ããŠçæéã®äœå ç眮ã«ãŠææé²æ¢èœåãå šã
倱ãªãããããšãæå³ãããåŸã€ãŠãæçç©è³ªã
å£é¢ããé¢ããŠããé床ãå¶åŸ¡ããé·æéã«ãã
ã€ãŠæçç©è³ªã®å°¿äžæ¿åºŠãšåŒã°ãããã®ãæå¹ãª
æ¿åºŠä»¥äžã«ä¿ã€ãŠããããšãææé²æ¢ã«ã¯å€§åãª
ããšãšãªãã
è·¯ç²èã®ééãéè¡ïŒç®¡å€æ§çµè·¯ïŒïŒå°å°¿ã«ã
ãŒãã«ãšå°ç®¡ãšã®çµåéšããã®äŸµå ¥ïŒæŽæµãªã©ã®
åŠçœ®ãå«ãïŒïŒèå°¿éšããå°ç®¡ããã³å°å°¿ã«ã
ãŒãã«å éšã®éè¡ïŒç®¡å æ§çµè·¯ïŒãããã管å€æ§
çµè·¯ããã®äŸµå ¥ã«ãŠã¯å°¿éåžžåšèãç眮åŸæ©æã«
ã¯å°å°¿ã«ããŒãã«ã®å£ãäŒã€ãŠéããã«äžè¡ãã
èè±é éšã«éããããã®ãããªææã«å¯ŸããŠã¯å°
å°¿ã«ããŒãã«ã®å£é¢ã«ååšããæçç©è³ªã¯çŽæ¥è
ãšæ¥ããããšãã§ããã®ã§æèæ©èœãçºæ®ãåŸ
ããããããªãã管å æ§çµè·¯ïŒäŸãã°éå°¿åšãã
ã®äŸµå ¥ïŒããªãã¡éå°¿åšã«èœäžãããã¯äŸµå ¥ãã
现èã¯ã貯çããŠããå°¿äžã§å¢æ®ããå°¿ã®éæµã
æ°æ³¡ã®äžæã«äŒŽã€ãŠèè±å ã«ãŸã§éãããå®éã
é眮å®éšã«ãããŠãé¯ã®æ»æãã®ããšãã«çŽ°èã
å°¿äžãé¡ãããšã確èªãããŠããããã®ãããªçµ
è·¯ããã®äŸµå ¥ã«å¯ŸããŠã¯ãå°å°¿ã«ããŒãã«ã®å£é¢
ã«ååšããæçç©è³ªã¯èãšçŽæ¥æ¥ããããšãã§ã
ãªãããšãèµ·ããåŸããããæèæ©èœã®åã°ãªã
èãæ®åããå¯èœæ§ãé«ããææé²æ¢èœåã¯å å
ã§ã¯ãªããå šãŠã®äŸµå ¥çµè·¯ããã®ææã«å¯ŸããŠé²
æ¢èœåãæã€ããã«ã¯ãæçç©è³ªã¯å°å°¿ã«ããŒã
ã«ã®å£é¢ã«ååšããã ãã§ãªããåŸã ã«å£é¢ãã
é¢ããŠå°¿äžã«æ¡æ£ããŠãããå°¿å ãæµ®éäžåãã
现èã«æ¥ããããšãå¿ èŠã§ããããã®å Žåãæç
ç©è³ªãå£é¢ããé¢ããŠããéã®é床ãåé¡ãšãª
ããåè¿°ã®ããšãå°å°¿ã«ããŒãã«ã«æçç©è³ªãåž
çãããããæçç©è³ªå ¥ãã®è»èãå¡åžãããã
ããã¯å£é¢ã«æš¹èãã³ãŒãã€ã³ã°ãããã®ã³ãŒã
ã€ã³ã°å±€ã«æçç©è³ªãå«ãŸããŠäœ¿çšãããããšã
æ¹æ³ãå®æœããå Žåã«ã¯ãæçç©è³ªã¯å°¿ã«ãã€ãŠ
ç°¡åã«æŽãæµããäœå€ã«æµåºãã極ããŠçæéã«
ãŠå£é¢ã«ãå°¿äžã«ãååšããªããªãããã®ããšã¯
極ããŠçæéã®äœå ç眮ã«ãŠææé²æ¢èœåãå šã
倱ãªãããããšãæå³ãããåŸã€ãŠãæçç©è³ªã
å£é¢ããé¢ããŠããé床ãå¶åŸ¡ããé·æéã«ãã
ã€ãŠæçç©è³ªã®å°¿äžæ¿åºŠãšåŒã°ãããã®ãæå¹ãª
æ¿åºŠä»¥äžã«ä¿ã€ãŠããããšãææé²æ¢ã«ã¯å€§åãª
ããšãšãªãã
æ¬çºæè
ãã¯ããã®ãããªçŸç¶ã«éã¿ã簡䟿ã«
䜿çšã§ããæ°ããªæææºãšãªãããšããªããé·æ
éã«ããã€ãŠç·ãŠã®äŸµå ¥çµè·¯ããã®ææã«ãé²æ¢
èœåãæããå°å°¿ã«ããŒãã«ãæäŸããããšãç®
çãšããŠéæç 究ãéããçµæããªã¬ãã€ã³ç³»é
åäœããžãšã³ç³»éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœã
çŽ æãšããå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«æ
çç©è³ªãã€ãªã³çµåãããå Žåããã®æçç©è³ªã¯
å°å°¿ã«ããŒãã«ã®äœå ç眮æã«çæéã«å°¿ã«ãã
æŽãæµããäœå€ã«æµåºããããšããªãããã€æãŸ
ããé床ã«ãŠåŸã ã«ã€ãªã³è§£é¢ã«ããå£ããé¢ã
ãŠå°¿äžã«æ¡æ£ãããã®çµæãæå¹ãªå°¿äžæ¿åºŠãé·
æéç¶æããããšãèŠåºããæ¬çºæã«å°éããã
ã®ã§ããã
䜿çšã§ããæ°ããªæææºãšãªãããšããªããé·æ
éã«ããã€ãŠç·ãŠã®äŸµå ¥çµè·¯ããã®ææã«ãé²æ¢
èœåãæããå°å°¿ã«ããŒãã«ãæäŸããããšãç®
çãšããŠéæç 究ãéããçµæããªã¬ãã€ã³ç³»é
åäœããžãšã³ç³»éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœã
çŽ æãšããå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«æ
çç©è³ªãã€ãªã³çµåãããå Žåããã®æçç©è³ªã¯
å°å°¿ã«ããŒãã«ã®äœå ç眮æã«çæéã«å°¿ã«ãã
æŽãæµããäœå€ã«æµåºããããšããªãããã€æãŸ
ããé床ã«ãŠåŸã ã«ã€ãªã³è§£é¢ã«ããå£ããé¢ã
ãŠå°¿äžã«æ¡æ£ãããã®çµæãæå¹ãªå°¿äžæ¿åºŠãé·
æéç¶æããããšãèŠåºããæ¬çºæã«å°éããã
ã®ã§ããã
ããªãã¡æ¬çºæã¯ããªã¬ãã€ã³ç³»éåäœãŸãã¯
ãžãšã³ç³»éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãš
ããå°å°¿ã«ããŒãã«ã«ãããŠã該ã«ããŒãã«ã®å
å£ãŸãã¯å€å£ã«æçç©è³ªãã€ãªã³çµåãããŠãã
ããšãç¹åŸŽãšããå°¿è·¯ææé²æ¢èœãæããå°å°¿ã«
ããŒãã«ã§ããã
ãžãšã³ç³»éåäœãŸãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãš
ããå°å°¿ã«ããŒãã«ã«ãããŠã該ã«ããŒãã«ã®å
å£ãŸãã¯å€å£ã«æçç©è³ªãã€ãªã³çµåãããŠãã
ããšãç¹åŸŽãšããå°¿è·¯ææé²æ¢èœãæããå°å°¿ã«
ããŒãã«ã§ããã
æ¬çºæã«ãããªã¬ãã€ã³ç³»éåäœãšã¯ãïŒåã®
äºéçµåãæããçåæ°ŽçŽ ãäŸãã°ãšãã¬ã³ãã
ããã¬ã³ãïŒâããã³ãïŒâã¡ãã«âïŒâãã
ã³ãïŒïŒïŒâãžã¡ãã«âïŒâããã³ãïŒâãã³ã
ã³ãïŒâã¡ãã«âïŒâãã³ãã³ãïŒâã¡ãã«âïŒ
âãã³ãã³ãïŒâããã»ã³ãïŒâã¡ãã«âïŒâã
ãã»ã³ãïŒâã¡ãã«âïŒâããã»ã³ãïŒâããã
ã³ãïŒâãªã¯ãã³ãïŒâãã»ã³ãïŒâãããµãã»
ã³ãïŒâãªã¯ã¿ãã»ã³ãããã«ã·ã¯ããããã³ã
ããã«ã·ã¯ããããµã³ãã€ãœããã¬ã³ãïŒâã¡ã
ã«âïŒâãã³ãã³ãã·ã¯ãããã³ããã«ãã«ãã³
ãªã©ãå ¬ç¥ã®æ¹æ³ã§åç¬ãããã¯å ±éåãããã
ã®ãããã
äºéçµåãæããçåæ°ŽçŽ ãäŸãã°ãšãã¬ã³ãã
ããã¬ã³ãïŒâããã³ãïŒâã¡ãã«âïŒâãã
ã³ãïŒïŒïŒâãžã¡ãã«âïŒâããã³ãïŒâãã³ã
ã³ãïŒâã¡ãã«âïŒâãã³ãã³ãïŒâã¡ãã«âïŒ
âãã³ãã³ãïŒâããã»ã³ãïŒâã¡ãã«âïŒâã
ãã»ã³ãïŒâã¡ãã«âïŒâããã»ã³ãïŒâããã
ã³ãïŒâãªã¯ãã³ãïŒâãã»ã³ãïŒâãããµãã»
ã³ãïŒâãªã¯ã¿ãã»ã³ãããã«ã·ã¯ããããã³ã
ããã«ã·ã¯ããããµã³ãã€ãœããã¬ã³ãïŒâã¡ã
ã«âïŒâãã³ãã³ãã·ã¯ãããã³ããã«ãã«ãã³
ãªã©ãå ¬ç¥ã®æ¹æ³ã§åç¬ãããã¯å ±éåãããã
ã®ãããã
æ¬çºæã«ãããžãšã³ç³»éåäœãšã¯ãäºéçµåã
ïŒåæããçåæ°ŽçŽ ãäŸãã°ãã¿ãžãšã³ãã€ãœã
ã¬ã³ãïŒïŒïŒâãã³ã¿ãžãšã³ãïŒïŒïŒâãããµãž
ãšã³ãïŒïŒïŒâããã¿ãžãšã³ãªã©ãå ¬ç¥ã®æ¹æ³ã§
åç¬ãããã¯å ±éåããããã®ããããäŸå€ãšã
ãŠã€ãœãã¬ã³ã®ã·ã¹âïŒïŒïŒâéåäœã¯å€©ç¶ãŽã
ãšããŠå€©ç¶ã«åºãååšãããããã®ãã®ãæ¬çºæ
ã«ãããŠå¥œãŸããå©çšãããã
ïŒåæããçåæ°ŽçŽ ãäŸãã°ãã¿ãžãšã³ãã€ãœã
ã¬ã³ãïŒïŒïŒâãã³ã¿ãžãšã³ãïŒïŒïŒâãããµãž
ãšã³ãïŒïŒïŒâããã¿ãžãšã³ãªã©ãå ¬ç¥ã®æ¹æ³ã§
åç¬ãããã¯å ±éåããããã®ããããäŸå€ãšã
ãŠã€ãœãã¬ã³ã®ã·ã¹âïŒïŒïŒâéåäœã¯å€©ç¶ãŽã
ãšããŠå€©ç¶ã«åºãååšãããããã®ãã®ãæ¬çºæ
ã«ãããŠå¥œãŸããå©çšãããã
å
±éåæåãšããŠã¯ãä»ã«ãäŸãã°é
¢é
žãã
ã«ãã¡ãã«ããã«ãšãŒãã«ãã¹ãã¬ã³ãå¡©åãã
ã«ãå¡©åãããªãã³ãç¡æ°Žãã¬ã€ã³é žãã¢ã¯ãªã«
é žãã¡ã¿ã¯ãªã«é žãã¢ã¯ãªããããªã«ãã¡ã¿ã¯ãª
ã«é žã¡ãã«ãäºé žåã€ãªãŠãããã«ããªãžã³ãã¯
ãããã¬ã³ããšãã¬ã³ãªãã·ãããã«ã ã¢ã«ãã
ããªã©ããããããã
ã«ãã¡ãã«ããã«ãšãŒãã«ãã¹ãã¬ã³ãå¡©åãã
ã«ãå¡©åãããªãã³ãç¡æ°Žãã¬ã€ã³é žãã¢ã¯ãªã«
é žãã¡ã¿ã¯ãªã«é žãã¢ã¯ãªããããªã«ãã¡ã¿ã¯ãª
ã«é žã¡ãã«ãäºé žåã€ãªãŠãããã«ããªãžã³ãã¯
ãããã¬ã³ããšãã¬ã³ãªãã·ãããã«ã ã¢ã«ãã
ããªã©ããããããã
æ¬çºæã«ããã·ãªã³ã³ç³»éåäœãšããŠã¯ãäŸã
ã°ãžã¡ãã«ããªã·ãããµã³ãã¡ãã«ããšãã«ããª
ã·ãããµã³ãã·ã¢ãã¢ã«ãã«ã¡ãã«ããªã·ãããµ
ã³ããããã¢ã«ãã«ã¡ãã«ã·ãããµã³ãªã©ããã
ããããããã®é«åŒŸåæ§ãé«åŒ·åºŠã人äœç¡å®³æ§ãª
ã©ã®é¢ãããžã¡ãã«ããªã·ãããµã³ããšãã«å¥œãŸ
ããã
ã°ãžã¡ãã«ããªã·ãããµã³ãã¡ãã«ããšãã«ããª
ã·ãããµã³ãã·ã¢ãã¢ã«ãã«ã¡ãã«ããªã·ãããµ
ã³ããããã¢ã«ãã«ã¡ãã«ã·ãããµã³ãªã©ããã
ããããããã®é«åŒŸåæ§ãé«åŒ·åºŠã人äœç¡å®³æ§ãª
ã©ã®é¢ãããžã¡ãã«ããªã·ãããµã³ããšãã«å¥œãŸ
ããã
æ¬çºæã«ãããŠçšããããæçç©è³ªãšããŠã¯ã
äŸãã°ãšãã«ã³ãã¯é žãšãªã¹ããã€ã·ã³ããšãã«
çé žãšãªã¹ããã€ã·ã³ãã°ã«ã³ãããã³é žãšãªã¹
ããã€ã·ã³ãã¹ãã¢ãªã³é žãšãªã¹ããã€ã·ã³ãã©
ãŠãªã«ç¡«é žããããªã³é žãšãªã¹ããã€ã·ã³ãã©ã¯
ãããªã³é žãšãªã¹ããã€ã·ã³ãããªã¢ã»ãã«ãªã¬
ã¢ã³ããã€ã·ã³ããªã³é žãªã¬ã¢ã³ããã€ã·ã³ãç¡«
é žã¢ãã«ã·ã³ãç¡«é žãã«ããã€ã·ã³ãã¢ããããª
ãã·ã«ããã€ã·ã³ãäžç¡«é žã«ããã€ã·ã³ãããã©
ãã€ã·ã³ãã¢ã»ãã«ãã¿ãµãã€ã·ã³ããã¿ãµãã€
ã·ã³ãã³ãã¯é žãã¿ãµãã€ã·ã³ãé ç³é žãã¿ãµã
ã€ã·ã³ãã¯ãã©ã ããšãã³ãŒã«ãã³ãã¯é žã¯ãã©
ã ããšãã³ãŒã«ã¢ã«ã®ãã³ãã³ãã¯é žã¯ãã©ã ã
ãšãã³ãŒã«ãããªãŠã ãã¹ãã¢ãªã³é žã¯ãã©ã ã
ãšãã³ãŒã«ãã¢ã«ããªãé ¢é žã¯ãã©ã ããšãã³ãŒ
ã«ããã«ããã³é žã¯ãã©ã ããšãã³ãŒã«ãã¹ãã¢
ãã€ã«ã°ãªã³ãŒã«é žã¯ãã©ã ããšãã³ãŒã«ãç¡«é ž
ã¢ã«ããªãé ¢é žã¯ãã©ã ããšãã³ãŒã«ãå¡©é žã³ãª
ã¹ãã³ãã³ãªã¹ãã³ãã³ãªã¹ãã³ã¡ã¿ã³ã¹ã«ãã³
é žãããªãŠã ãç¡«é žã³ãªã¹ãã³ããžãšãµãã€ã·
ã³ãããããªã³é žãžãšãµãã€ã·ã³ãå¡©é žãžããã
ã¹ãã¬ãããã€ã·ã³ãç¡«é žãžãããã¹ãã¬ããã
ã€ã·ã³ãè€åã¹ãã¬ãããã€ã·ã³ãå¡©é žã¹ãã¬ã
ããã€ã·ã³ãå¡©é žã¹ãã¬ãããã€ã·ã³å¡©åã«ã«ã·
ãŠã ãç¡«é žã¹ãã¬ãããã€ã·ã³ãç¡«é žã¹ãã¬ãã
ãã€ã·ã³ã€ãœãã¢ãŸãŒã³ãã»ãã¢ã»ããªã«ãããª
ãŠã ãã»ãã¢ãŸãªã³ãããªãŠã ãã»ãã¢ããªã³ã
ããªãŠã ãã»ãã¢ã¬ãã·ã³ãã»ãã¢ã°ãªã·ã³ãã»
ãã¢ããã³ãããªãŠã ãã»ãã¢ããªãžã³ãã»ãã
ãŸãŒã«ãããªãŠã ãã»ãã©ãžã³ãã»ãã¢ã¡ãŸã³ã
å¡©é žãªãã·ããã©ãµã€ã¯ãªã³ããªãã·ããã©ãµã€
ã¯ãªã³ããªãã·ããã©ãµã€ã¯ãªã³ã«ã«ã·ãŠã ãå¡©
é žã¯ãã«ããã©ãµã€ã¯ãªã³ãã¯ãã«ããã©ãµã€ã¯
ãªã³ãå¡©é žããã©ãµã€ã¯ãªã³ãç¡é žããªããã©ãµ
ã€ã¯ãªã³ãããã©ãµã€ã¯ãªã³ã¡ãã¬ã³ãªãžã³ãã¡
ã¿ãªã³é žããã©ãµã€ã¯ãªã³ãããªããã©ãµã€ã¯ãª
ã³ãå¡©é žãžã¡ãã«ã¯ãã«ããã©ãµã€ã¯ãªã³ããã¡
ãã«ã¯ãã«ããã©ãµã€ã¯ãªã³ãå¡©é žããã·ãµã€ã¯
ãªã³ãå¡©é žãããµã€ã¯ãªã³ãå¡©é žã¡ã¿ãµã€ã¯ãª
ã³ãã¢ã¯ãããã€ã·ã³ïŒ€ãã¢ã¶ããã€ã·ã³ïŒŠãã¢
ã ãããªã·ã³ïŒ¢ãç¡«é žãšã³ããªãã€ã·ã³ãå¡©é žãš
ã³ã©ãã€ã·ã³ããªãŒã¬ãªã¹ãªã·ã³ãç¡«é žã«ãã¬ãª
ãã€ã·ã³ãã«ã«ãããã€ãªã³ãã«ã«ããã€ã·ã³ã
ã°ã©ãã·ãžã³ãå¡©é žã°ã©ãã·ãžã³ïŒ³ãã°ãªã»ãªã
ã«ãã³ãã¯ãã¢ãã€ã·ã³A3ãç¡«é žã²ã³ã¿ãã€ã·
ã³ããµã€ã¯ãã»ãªã³ãã¶ã«ã³ãã€ã·ã³ãã·ãã«ã
ã³ãç¡«é žãžãã«ã·ã³ãã¢ã»ãã«ã¹ãã©ãã€ã·ã³ã
ã¹ãã©ãã€ã·ã³ãå¡©é žã¹ãã¯ãããã€ã·ã³ãå¡©é ž
ããŠãã«ãã·ã³ãå¡©é žãããœã«ãã·ã³ãããªã³ã
ã€ã·ã³ããã€ã¹ã¿ãã³ãããªã«ã«ããã¹ã¿ãã³ã
ããããªã·ã³ã«ã«ã·ãŠã ãããããªã·ã³ãããªãŠ
ã ãç¡«é žãã€ãªãã€ã·ã³ããã·ãã©ã·ã³ãããªãª
ãã³ãç¡«é žããã¢ãã€ã·ã³ããããªã·ã³ããããŒ
ã«ãããªã³ããã·ãžã³é žãããªãŠã ããã«ããã³
é žãã©ãžãªãã€ã·ã³ãç¡«é žãã©ãžãªãã€ã·ã³ãå¡©
é žãã¬ãªãã€ã·ã³ãç¡«é žãã¬ãªãã€ã·ã³ãã¢ã³ã
ã·ãªã³ãã¢ã³ãã·ãªã³ãããªãŠã ãå¡©é žã¢ã³ãã·
ãªã³ãã¿ãªãžã«ãã«ã«ããã·ãªã³ãããªãŠã ãã«
ã«ããã·ãªã³ã€ã³ã¿ãã«ãããªãŠã ãã«ã«ããã·
ãªã³ããšãã«ãããªãŠã ãããšããã·ã¡ãã«ãã
ã·ãªã³ãããšããã·ã¡ãã«ããã·ãªã³ã«ãªãŠã ã
ããšããã·ã¡ãã«ããã·ãªã³ã«ã«ã·ãŠã ãããšã
ãã·ã¡ãã«ããã·ãªã³ãã³ã¶ãã³ãããã·ãªã³ã«
ãªãŠã ãããã·ãªã³ãããªãŠã ãããã·ãªã³ãã
ã«ã€ã³ããã³ãžã«ããã·ãªã³ã¢ããã¡ãããžã³ã
ãã³ãžã«ããã·ãªã³ã«ãªãŠã ããã³ãžã«ããã·ãª
ã³ãããªãŠã ããã³ãžã«ããã·ãªã³ããã«ã€ã³ã
ãã³ãžã«ããã·ãªã³ãã³ã¶ãã³ãè€åããã·ãªã³
ã«ãªãŠã ãè€åãã³ãžã«ããã·ãªã³ã«ãªãŠã ãè€
åãã³ãžã«ããã·ãªã³ãããªãŠã ãè€åãã³ãžã«
ããã·ãªã³ãã³ã¶ãã³ãå¡©é žã¯ãªã³ããã€ã·ã³ã
å¡©é žãã«ããã³é žã¯ãªã³ããã€ã·ã³ãå¡©é žãªã³ã³
ãã€ã·ã³ãã¢ã¢ãã·ãªã³ããªããµã·ãªã³ãããªãŠ
ã ãã¯ãããµã·ãªã³ãããªãŠã ãã·ã¯ã©ã·ãªã³ã
ãžã¯ãããµã·ãªã³ãããªãŠã ãã¹ã«ããã·ãªã³ã
ããªãŠã ãå¡©é žããã¡ã·ãªãã ãããšããã·ãªã³
ã«ãªãŠã ããã«ã¯ãããµã·ãªã³ãããªãŠã ããã
ãã·ãªã³ã«ãªãŠã ããã¿ã·ãªã³ã«ãªãŠã ãã¡ãã·
ãªã³ãããªãŠã ããã³ã¿ãã€ã·ã³ãç¡«é žããªãã
ã·ã³ïŒ¢ããã€ããã€ã·ã³ïŒ£ãããããªã³é žããªã
ãã€ã·ã³ããã«ãã€ã·ã³ãããã«ãã€ã·ã³ããªã
ã¢ã³ãã·ã³ãç¡«é žãªãã¹ã¿ãã€ã·ã³ãªã©ãããã
ãããããã¯åç¬ãŸãã¯ïŒçš®ä»¥äžçµã¿åãããŠäœ¿
çšããããšãã§ããã
äŸãã°ãšãã«ã³ãã¯é žãšãªã¹ããã€ã·ã³ããšãã«
çé žãšãªã¹ããã€ã·ã³ãã°ã«ã³ãããã³é žãšãªã¹
ããã€ã·ã³ãã¹ãã¢ãªã³é žãšãªã¹ããã€ã·ã³ãã©
ãŠãªã«ç¡«é žããããªã³é žãšãªã¹ããã€ã·ã³ãã©ã¯
ãããªã³é žãšãªã¹ããã€ã·ã³ãããªã¢ã»ãã«ãªã¬
ã¢ã³ããã€ã·ã³ããªã³é žãªã¬ã¢ã³ããã€ã·ã³ãç¡«
é žã¢ãã«ã·ã³ãç¡«é žãã«ããã€ã·ã³ãã¢ããããª
ãã·ã«ããã€ã·ã³ãäžç¡«é žã«ããã€ã·ã³ãããã©
ãã€ã·ã³ãã¢ã»ãã«ãã¿ãµãã€ã·ã³ããã¿ãµãã€
ã·ã³ãã³ãã¯é žãã¿ãµãã€ã·ã³ãé ç³é žãã¿ãµã
ã€ã·ã³ãã¯ãã©ã ããšãã³ãŒã«ãã³ãã¯é žã¯ãã©
ã ããšãã³ãŒã«ã¢ã«ã®ãã³ãã³ãã¯é žã¯ãã©ã ã
ãšãã³ãŒã«ãããªãŠã ãã¹ãã¢ãªã³é žã¯ãã©ã ã
ãšãã³ãŒã«ãã¢ã«ããªãé ¢é žã¯ãã©ã ããšãã³ãŒ
ã«ããã«ããã³é žã¯ãã©ã ããšãã³ãŒã«ãã¹ãã¢
ãã€ã«ã°ãªã³ãŒã«é žã¯ãã©ã ããšãã³ãŒã«ãç¡«é ž
ã¢ã«ããªãé ¢é žã¯ãã©ã ããšãã³ãŒã«ãå¡©é žã³ãª
ã¹ãã³ãã³ãªã¹ãã³ãã³ãªã¹ãã³ã¡ã¿ã³ã¹ã«ãã³
é žãããªãŠã ãç¡«é žã³ãªã¹ãã³ããžãšãµãã€ã·
ã³ãããããªã³é žãžãšãµãã€ã·ã³ãå¡©é žãžããã
ã¹ãã¬ãããã€ã·ã³ãç¡«é žãžãããã¹ãã¬ããã
ã€ã·ã³ãè€åã¹ãã¬ãããã€ã·ã³ãå¡©é žã¹ãã¬ã
ããã€ã·ã³ãå¡©é žã¹ãã¬ãããã€ã·ã³å¡©åã«ã«ã·
ãŠã ãç¡«é žã¹ãã¬ãããã€ã·ã³ãç¡«é žã¹ãã¬ãã
ãã€ã·ã³ã€ãœãã¢ãŸãŒã³ãã»ãã¢ã»ããªã«ãããª
ãŠã ãã»ãã¢ãŸãªã³ãããªãŠã ãã»ãã¢ããªã³ã
ããªãŠã ãã»ãã¢ã¬ãã·ã³ãã»ãã¢ã°ãªã·ã³ãã»
ãã¢ããã³ãããªãŠã ãã»ãã¢ããªãžã³ãã»ãã
ãŸãŒã«ãããªãŠã ãã»ãã©ãžã³ãã»ãã¢ã¡ãŸã³ã
å¡©é žãªãã·ããã©ãµã€ã¯ãªã³ããªãã·ããã©ãµã€
ã¯ãªã³ããªãã·ããã©ãµã€ã¯ãªã³ã«ã«ã·ãŠã ãå¡©
é žã¯ãã«ããã©ãµã€ã¯ãªã³ãã¯ãã«ããã©ãµã€ã¯
ãªã³ãå¡©é žããã©ãµã€ã¯ãªã³ãç¡é žããªããã©ãµ
ã€ã¯ãªã³ãããã©ãµã€ã¯ãªã³ã¡ãã¬ã³ãªãžã³ãã¡
ã¿ãªã³é žããã©ãµã€ã¯ãªã³ãããªããã©ãµã€ã¯ãª
ã³ãå¡©é žãžã¡ãã«ã¯ãã«ããã©ãµã€ã¯ãªã³ããã¡
ãã«ã¯ãã«ããã©ãµã€ã¯ãªã³ãå¡©é žããã·ãµã€ã¯
ãªã³ãå¡©é žãããµã€ã¯ãªã³ãå¡©é žã¡ã¿ãµã€ã¯ãª
ã³ãã¢ã¯ãããã€ã·ã³ïŒ€ãã¢ã¶ããã€ã·ã³ïŒŠãã¢
ã ãããªã·ã³ïŒ¢ãç¡«é žãšã³ããªãã€ã·ã³ãå¡©é žãš
ã³ã©ãã€ã·ã³ããªãŒã¬ãªã¹ãªã·ã³ãç¡«é žã«ãã¬ãª
ãã€ã·ã³ãã«ã«ãããã€ãªã³ãã«ã«ããã€ã·ã³ã
ã°ã©ãã·ãžã³ãå¡©é žã°ã©ãã·ãžã³ïŒ³ãã°ãªã»ãªã
ã«ãã³ãã¯ãã¢ãã€ã·ã³A3ãç¡«é žã²ã³ã¿ãã€ã·
ã³ããµã€ã¯ãã»ãªã³ãã¶ã«ã³ãã€ã·ã³ãã·ãã«ã
ã³ãç¡«é žãžãã«ã·ã³ãã¢ã»ãã«ã¹ãã©ãã€ã·ã³ã
ã¹ãã©ãã€ã·ã³ãå¡©é žã¹ãã¯ãããã€ã·ã³ãå¡©é ž
ããŠãã«ãã·ã³ãå¡©é žãããœã«ãã·ã³ãããªã³ã
ã€ã·ã³ããã€ã¹ã¿ãã³ãããªã«ã«ããã¹ã¿ãã³ã
ããããªã·ã³ã«ã«ã·ãŠã ãããããªã·ã³ãããªãŠ
ã ãç¡«é žãã€ãªãã€ã·ã³ããã·ãã©ã·ã³ãããªãª
ãã³ãç¡«é žããã¢ãã€ã·ã³ããããªã·ã³ããããŒ
ã«ãããªã³ããã·ãžã³é žãããªãŠã ããã«ããã³
é žãã©ãžãªãã€ã·ã³ãç¡«é žãã©ãžãªãã€ã·ã³ãå¡©
é žãã¬ãªãã€ã·ã³ãç¡«é žãã¬ãªãã€ã·ã³ãã¢ã³ã
ã·ãªã³ãã¢ã³ãã·ãªã³ãããªãŠã ãå¡©é žã¢ã³ãã·
ãªã³ãã¿ãªãžã«ãã«ã«ããã·ãªã³ãããªãŠã ãã«
ã«ããã·ãªã³ã€ã³ã¿ãã«ãããªãŠã ãã«ã«ããã·
ãªã³ããšãã«ãããªãŠã ãããšããã·ã¡ãã«ãã
ã·ãªã³ãããšããã·ã¡ãã«ããã·ãªã³ã«ãªãŠã ã
ããšããã·ã¡ãã«ããã·ãªã³ã«ã«ã·ãŠã ãããšã
ãã·ã¡ãã«ããã·ãªã³ãã³ã¶ãã³ãããã·ãªã³ã«
ãªãŠã ãããã·ãªã³ãããªãŠã ãããã·ãªã³ãã
ã«ã€ã³ããã³ãžã«ããã·ãªã³ã¢ããã¡ãããžã³ã
ãã³ãžã«ããã·ãªã³ã«ãªãŠã ããã³ãžã«ããã·ãª
ã³ãããªãŠã ããã³ãžã«ããã·ãªã³ããã«ã€ã³ã
ãã³ãžã«ããã·ãªã³ãã³ã¶ãã³ãè€åããã·ãªã³
ã«ãªãŠã ãè€åãã³ãžã«ããã·ãªã³ã«ãªãŠã ãè€
åãã³ãžã«ããã·ãªã³ãããªãŠã ãè€åãã³ãžã«
ããã·ãªã³ãã³ã¶ãã³ãå¡©é žã¯ãªã³ããã€ã·ã³ã
å¡©é žãã«ããã³é žã¯ãªã³ããã€ã·ã³ãå¡©é žãªã³ã³
ãã€ã·ã³ãã¢ã¢ãã·ãªã³ããªããµã·ãªã³ãããªãŠ
ã ãã¯ãããµã·ãªã³ãããªãŠã ãã·ã¯ã©ã·ãªã³ã
ãžã¯ãããµã·ãªã³ãããªãŠã ãã¹ã«ããã·ãªã³ã
ããªãŠã ãå¡©é žããã¡ã·ãªãã ãããšããã·ãªã³
ã«ãªãŠã ããã«ã¯ãããµã·ãªã³ãããªãŠã ããã
ãã·ãªã³ã«ãªãŠã ããã¿ã·ãªã³ã«ãªãŠã ãã¡ãã·
ãªã³ãããªãŠã ããã³ã¿ãã€ã·ã³ãç¡«é žããªãã
ã·ã³ïŒ¢ããã€ããã€ã·ã³ïŒ£ãããããªã³é žããªã
ãã€ã·ã³ããã«ãã€ã·ã³ãããã«ãã€ã·ã³ããªã
ã¢ã³ãã·ã³ãç¡«é žãªãã¹ã¿ãã€ã·ã³ãªã©ãããã
ãããããã¯åç¬ãŸãã¯ïŒçš®ä»¥äžçµã¿åãããŠäœ¿
çšããããšãã§ããã
ãããæçç©è³ªã¯å°å°¿ã«ããŒãã«ã®å
å£ãŸãã¯
å€å£ã«çŽæ¥ã€ãªã³çµåããããããã¯å°å°¿ã«ããŒ
ãã«ã®å å£ãŸãã¯å€å£ã«èšããããã³ãŒãã€ã³ã°
å±€ã«ã€ãªã³çµåãããã
å€å£ã«çŽæ¥ã€ãªã³çµåããããããã¯å°å°¿ã«ããŒ
ãã«ã®å å£ãŸãã¯å€å£ã«èšããããã³ãŒãã€ã³ã°
å±€ã«ã€ãªã³çµåãããã
æ¬çºæã®å°å°¿ã«ããŒãã«ã¯ä»¥äžã«ãããæ¹æ³ã§
調補ããããšãã§ããã
調補ããããšãã§ããã
(1) æ圢åã®éåäœãŸãã¯æ圢åŸã®å°å°¿ã«ããŒã
ã«ã«ã€ãªã³äº€æåºãå°å ¥ããå°å ¥ãããã€ãªã³
亀æåºãšæçç©è³ªãã€ãªã³çµåãããã
ã«ã«ã€ãªã³äº€æåºãå°å ¥ããå°å ¥ãããã€ãªã³
亀æåºãšæçç©è³ªãã€ãªã³çµåãããã
(2) æ圢åã®éåäœãŸãã¯æ圢åŸã®å°å°¿ã«ããŒã
ã«ã«åå¿æ§å®èœåºãå°å ¥ããã€ãã§ãã®éåäœ
ãŸãã¯å°å°¿ã«ããŒãã«ã«ãå°å ¥ãããåå¿æ§å®
èœåºãšå ±æçµå圢æèœãæããå®èœåºããã€å
åç©ãã³ãŒãã€ã³ã°ããŠãã®ååç©ã®å®èœåºãš
å°å ¥ãããåå¿æ§å®èœåºãšãå ±æçµåãããã
ãããã®ã¡ã³ãŒãã€ã³ã°å±€ã®æªåå¿ã®å®èœåºã
ã€ãªã³åãããã®ã€ãªã³äº€æåºãšæçç©è³ªãã€
ãªã³çµåãããã
ã«ã«åå¿æ§å®èœåºãå°å ¥ããã€ãã§ãã®éåäœ
ãŸãã¯å°å°¿ã«ããŒãã«ã«ãå°å ¥ãããåå¿æ§å®
èœåºãšå ±æçµå圢æèœãæããå®èœåºããã€å
åç©ãã³ãŒãã€ã³ã°ããŠãã®ååç©ã®å®èœåºãš
å°å ¥ãããåå¿æ§å®èœåºãšãå ±æçµåãããã
ãããã®ã¡ã³ãŒãã€ã³ã°å±€ã®æªåå¿ã®å®èœåºã
ã€ãªã³åãããã®ã€ãªã³äº€æåºãšæçç©è³ªãã€
ãªã³çµåãããã
(3) å°å°¿ã«ããŒãã«ã«ã€ãªã³äº€æåºãæããåå
ç©ãã³ãŒãã€ã³ã°ããã€ãã§ã³ãŒãã€ã³ã°å±€ã®
ã€ãªã³äº€æåºãšæçç©è³ªãå ±æçµåãããã
ç©ãã³ãŒãã€ã³ã°ããã€ãã§ã³ãŒãã€ã³ã°å±€ã®
ã€ãªã³äº€æåºãšæçç©è³ªãå ±æçµåãããã
ãããã®æ¹æ³ã«ããã°ãæçç©è³ªã¯ã€ãªã³çµå
ã«ãŠå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«ä¿æãã
ãŠããã®ã§ãåã«ç©ççåžçãå¡åžãªã©ã«ããä¿
æãããæçç©è³ªã®ããã«äœå ç眮åŸçæéã§å°¿
ã«ããäœå€ã«æµåºããããããªããšã¯ãªãããŸ
ããã€ãªã³çµåã¯å°¿ã®PHããã³å°¿äžã®éå±ã€ãªã³
ã®åœ±é¿ã®ããåŸã ã«è§£é¢ãããã®çµæãšããŠæç
ç©è³ªã¯å°¿äžã«åŸã ã«æ¡æ£ããŠããããšãšãªãé·æ
éã«ããã€ãŠæçç©è³ªã®å°¿äžæ¿åºŠãæå¹æ¿åºŠä»¥äž
ã«ä¿ãããã
ã«ãŠå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«ä¿æãã
ãŠããã®ã§ãåã«ç©ççåžçãå¡åžãªã©ã«ããä¿
æãããæçç©è³ªã®ããã«äœå ç眮åŸçæéã§å°¿
ã«ããäœå€ã«æµåºããããããªããšã¯ãªãããŸ
ããã€ãªã³çµåã¯å°¿ã®PHããã³å°¿äžã®éå±ã€ãªã³
ã®åœ±é¿ã®ããåŸã ã«è§£é¢ãããã®çµæãšããŠæç
ç©è³ªã¯å°¿äžã«åŸã ã«æ¡æ£ããŠããããšãšãªãé·æ
éã«ããã€ãŠæçç©è³ªã®å°¿äžæ¿åºŠãæå¹æ¿åºŠä»¥äž
ã«ä¿ãããã
äžèšã®ã€ãªã³äº€æåºãšããŠã¯ãäŸãã°ã¢ã³ã¢ã
ãŠã å¡©ãã«ã«ããã·ã¬ãŒãå¡©ãã¹ã«ãããŒãå¡©ãª
ã©ããããããåå¿æ§å®èœåºãšããŠã¯ã¢ããåºã
ã«ã«ããã·ã«åºãé žç¡æ°Žç©åºãã€ãœã·ã¢ããŒã
åºãã¹ã«ãã³é žåºãããã¢ã¢ã»ãã«åºãã€ããã«
ãŒãããŒãåºãªã©ããããããã
ãŠã å¡©ãã«ã«ããã·ã¬ãŒãå¡©ãã¹ã«ãããŒãå¡©ãª
ã©ããããããåå¿æ§å®èœåºãšããŠã¯ã¢ããåºã
ã«ã«ããã·ã«åºãé žç¡æ°Žç©åºãã€ãœã·ã¢ããŒã
åºãã¹ã«ãã³é žåºãããã¢ã¢ã»ãã«åºãã€ããã«
ãŒãããŒãåºãªã©ããããããã
éåäœã«äžèšã®ããšãåå¿æ§å®èœåºãå°å
¥ãã
ã«ã¯ãäŸãã°ä»¥äžã«ããããã®æ¹æ³ãæ¡çšã
ãããšãã§ãããããªã¬ãã€ã³ç³»éåäœã«ã€ããŠ
ã¯ããžãšã³ç³»éåäœã«ã€ããŠã¯
ãã·ãªã³ã³ç³»éåäœã«ã€ããŠã¯ã®æ¹æ³ã奜
ãŸããé©çšãããã
ã«ã¯ãäŸãã°ä»¥äžã«ããããã®æ¹æ³ãæ¡çšã
ãããšãã§ãããããªã¬ãã€ã³ç³»éåäœã«ã€ããŠ
ã¯ããžãšã³ç³»éåäœã«ã€ããŠã¯
ãã·ãªã³ã³ç³»éåäœã«ã€ããŠã¯ã®æ¹æ³ã奜
ãŸããé©çšãããã
ã¢ã¯ãªã«é
žãã¡ã¿ã¯ãªã«é
žãç¡æ°Žãã¬ã€ã³é
ž
ãªã©ã®åå¿æ§å®èœåºãæããããã«ã¢ãããŒã
ãªã¬ãã€ã³ããžãšã³ãã·ãªã³ã³ãšå ±éåããã
ããšã«ãããã«ã«ããã·ã«åºãé žç¡æ°Žç©åºãªã©
ãå°å ¥ãããããã«ã«ã«ããã·ã«åºã¯ã¯ãã«å
ããããšã«ããã¯ãããã«ãã«åºã«ãã°ãªã·ãž
ã«åããããšã«ãããšããã·åºã«å€ããããšã
ã§ããããŸããã«ã«ããã·ã«åºã¯é žããã©ãžã
åºããžãŠã¢ãžãåºã«å€ããããšãã§ããã
ãªã©ã®åå¿æ§å®èœåºãæããããã«ã¢ãããŒã
ãªã¬ãã€ã³ããžãšã³ãã·ãªã³ã³ãšå ±éåããã
ããšã«ãããã«ã«ããã·ã«åºãé žç¡æ°Žç©åºãªã©
ãå°å ¥ãããããã«ã«ã«ããã·ã«åºã¯ã¯ãã«å
ããããšã«ããã¯ãããã«ãã«åºã«ãã°ãªã·ãž
ã«åããããšã«ãããšããã·åºã«å€ããããšã
ã§ããããŸããã«ã«ããã·ã«åºã¯é žããã©ãžã
åºããžãŠã¢ãžãåºã«å€ããããšãã§ããã
ã¢ã³ã¢ãã¢ã®ååšäžãŸãã¯çªçŽ ãšæ°ŽçŽ ã®æ··å
ã¬ã¹ã®ååšäžã«ãã©ãºãåŠçããããšã«ããã¢
ããåºãå°å ¥ããã
ã¬ã¹ã®ååšäžã«ãã©ãºãåŠçããããšã«ããã¢
ããåºãå°å ¥ããã
éãã³ã¬ã³é
žã«ãªãŠã ãªã©ã®é
žåå€ãçšããŠ
å éšäºéçµåãæ°Žé žåºã«å€ãããæ°Žé žåºã¯ãã
ã ã¢ã»ãã«ããããã«ããããã ã¢ã»ãã«åã
ãã€ããã«ãŒãããŒãåºã«å€ããããšãã§ã
ãã
å éšäºéçµåãæ°Žé žåºã«å€ãããæ°Žé žåºã¯ãã
ã ã¢ã»ãã«ããããã«ããããã ã¢ã»ãã«åã
ãã€ããã«ãŒãããŒãåºã«å€ããããšãã§ã
ãã
ã¹ã«ãã¯ãã«åããå æ°Žå解ããããšã«ãã
ã¹ã«ãããŒãåºãå°å ¥ããã
ã¹ã«ãããŒãåºãå°å ¥ããã
éé
žãéé
žåæ°ŽçŽ ãããã¯éé
¢é
žãçšããŠãš
ããã·åºãå°å ¥ããã
ããã·åºãå°å ¥ããã
ïŒç¡æ°ŽïŒãã¬ã€ã³é
žã«ããå€æ§ããŠé
žïŒç¡æ°Ž
ç©ïŒåºãå°å ¥ããã
ç©ïŒåºãå°å ¥ããã
ã·ãŠãŠé
žãžã¯ããªããçšããŠã¯ãã«ãã«ãã«
åããã
åããã
γâã¢ãããããã«ããªãšããã·ã·ã©ã³ã«ãŠ
åŠçãã¢ããåºãå°å ¥ããã
åŠçãã¢ããåºãå°å ¥ããã
éåäœãžã®ã€ãªã³äº€æåºã®å°å
¥ã¯åè¿°ã®ããšã
æ¹æ³ã§å°å ¥ãããã¢ããåºãã¹ã«ãã³é žåºãã«ã«
ããã·ã«åºãªã©ã®åå¿æ§å®èœåºãå æ°Žå解ããã
ãããã¯ïŒçŽå¡©åãããªã©ã®å ¬ç¥ã®æ¹æ³ã§ã€ãªã³
åããããšã«ããéæãããã
æ¹æ³ã§å°å ¥ãããã¢ããåºãã¹ã«ãã³é žåºãã«ã«
ããã·ã«åºãªã©ã®åå¿æ§å®èœåºãå æ°Žå解ããã
ãããã¯ïŒçŽå¡©åãããªã©ã®å ¬ç¥ã®æ¹æ³ã§ã€ãªã³
åããããšã«ããéæãããã
åèš(2)ããã³(3)ã®æ¹æ³ã«ãããã³ãŒãã€ã³ã°ã«
çšããããååç©ãšããŠã¯ãäŸãã°ã°ã«ã¿ã«ã¢ã«
ãããããã¬ãã¿ã«ã¢ã«ããããã€ãœãã¿ã«ã¢ã«
ãããããžã¢ã«ãããã§ãã·ããªã©ã®ããªã¢ã«ã
ããããããµã¡ãã¬ã³ãžã€ãœã·ã¢ããŒãããã«ãš
ã³ãžã€ãœã·ã¢ããŒãããã·ã¬ã³ãžã€ãœã·ã¢ããŒ
ããããšãã¬ã³ãžã€ãœã·ã¢ããŒããã¢ããªã³âã
ã«ã ã¢ã«ãããã®ã€ãœã·ã¢ããŒãèªå°äœãªã©ã®ã
ãªã€ãœã·ã¢ããŒããå¡©åã¢ãžãã€ã«ãå¡©åã€ãœã
ã¿ãã€ã«ãå¡©åãã¬ãã¿ããŒã«ãå¡©åã·ã¢ãã«ãª
ã©ã®é žå¡©åç©ããããµã¡ãã¬ã³ããªã€ãœã·ã¢ããŒ
ããªã©ã®ããªããªã€ãœã·ã¢ããŒããïŒNâ²âãš
ãã¬ã³ãã¹ãšãŒãã¢ã»ãã¢ãããªã©ã®ïŒ®ïŒNâ²â
ããªã¡ãã¬ã³ãã¹ãšãŒãã¢ã»ãã¢ãããããã©ã¡
ãã¬ã³ã°ãªã³ãŒã«ãã°ãªã·ãžã«ãšãŒãã«ããžãšã
ã¬ã³ã°ãªã³ãŒã«ã®ãžã°ãªã·ãžã«ãšãŒãã«ãªã©ã®ã
ãªãšããã·ããããªç¡æ°Žãã¬ã€ã³é žãããªã€ã¿ã³
ã³é žç¡æ°Žç©ãç¡æ°Žãã¬ã€ã³é žâãã¿ã³ãžãªãŒã«ãž
ããã«ãšãŒãã«å ±éåäœãç¡æ°Žãã¬ã€ã³é žâããª
ãããã¬ã³ã°ã©ããå ±éåäœãç¡æ°Žãã¬ã€ã³é žâ
ã¡ãã«ããã«ãšãŒãã«å ±éåäœãç¡æ°Žãã¬ã€ã³é ž
âãšãã¬ã³å ±éåäœãç¡æ°Žãã¬ã€ã³é žâã¹ãã¬ã³
å ±éåäœãªã©ã®ããªã«ã«ãã³é žç¡æ°Žç©ãïŒ
Nâ²âãšãã¬ã³ãã¹ãã¬ã€ãããªã©ã®ãã¹ãã¬ã€
ãããïŒNâ²âã¡ãã¬ã³ãã¹ïŒã¡ã¿ïŒã¢ã¯ãªã«
ã¢ãããïŒNâ²âãããµã¡ãã¬ã³ãã¹ïŒã¡ã¿ïŒ
ã¢ã¯ãªã«ã¢ãããïŒNâ²ïŒNâ³âããªã¢ã¯ãªãã€
ã«ãããµãããããªã¢ãžã³ãªã©ã®ããªïŒã¡ã¿ïŒã¢
ã¯ãªãã€ã«ååç©ãã¢ã«ã®ã³é žããã¯ãã«é žãã¢
ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žããã¬ã€ã³é žãããã«
é žãã€ã¿ã³ã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã¿ãã³é ž
ãªã©ã®ãã¢ããªããŒãããã¯ã³ããªããŒãããã¯
ãããã®é žãšã¡ãã«ããšãã«ããããã«ããã
ã«ãã¢ãã«ãããã·ã«ããªã¯ãã«ãããã·ã«ãªã©
ãšã®ã¢ã«ãã«ãšã¹ãã«ãã¯ãã«ã¡ãã«ãïŒâã¯ã
ã«ãšãã«ãïŒâããã ãšãã«ãªã©ãšã®ããã²ã³å
ã¢ã«ãã«ãšã¹ãã«ãïŒâãšããã·ãšãã«ãïŒâã
ããã·ãšãã«ãïŒâïŒïŒâãšããã·ã¡ããã·ïŒãš
ãã«ãããšããã·ãšãã«ãã°ãªã·ãžã«ãªã©ãšãŒã
ã«åºãæãããã®ãšã®ãšã¹ãã«ãïŒâã¢ãããšã
ã«ãïŒâïŒNâ²âãžã¡ãã«ã¢ãããšãã«ãïŒâ
ïŒNâ²âãžãšãã«ã¢ãããšãã«ãïŒâïŒNâ²â
ãžãããã«ã¢ãããšãã«ãªã©å¡©åºæ§çªçŽ ãæãã
ãã®ãšã®ãšã¹ãã«ããšãã¬ã³ã°ãªã³ãŒã«ããžãšã
ã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããª
ãšãã¬ã³ã°ãªã³ãŒã«ãªã©ãšã®ã¢ããšã¹ãã«ããã
ã¯ãžãšã¹ãã«ãªã©ããããããããã«ã¯ã¢ã»ãã«
ã»ã«ããŒã¹ãããããªã³é žã»ã«ããŒã¹ãé ªé žã»ã«
ããŒã¹ããããã»ã«ããŒã¹ãé ¢é žã»ã«ããŒã¹ããª
ã³é žã»ã«ããŒã¹ããžããªã«ã«ãã³é žã»ã«ããŒã¹ãª
ã©ã®ã»ã«ããŒã¹ã®ãšã¹ãã«åèªå°äœãã¡ãã«ã»ã«
ããŒã¹ããšãã«ã»ã«ããŒã¹ããã³ãžã«ã»ã«ããŒ
ã¹ãããªã¡ãã«ã»ã«ããŒã¹ãã·ã¢ããšãã«ã»ã«ã
ãŒã¹ãã¢ãããšãã«ã»ã«ããŒã¹ããªãã·ãšãã«ã»
ã«ããŒã¹ãªã©ã®ã»ã«ããŒã¹ã®ãšãŒãã«åèªå°äœã
ããªããã«ã¢ã«ã³ãŒã«ãããªããã«ã¢ã«ã³ãŒã«ãš
ãšãã¬ã³ããããã¬ã³ãå¡©åããã«ãã¢ãªã«ã¢ã«
ã³ãŒã«ãâããã«ãããªãã³ãªã©ãšã®å ±éå
äœãããªããã«ã¢ã«ã³ãŒã«ã®ã¡ãã«ããšãã«ãã
ããã«ãããã«ããªã¯ãã«ãããã·ã«ãããšãã«
ãªã©ã®ãšãŒãã«èªå°äœãããªããã«ã¢ã«ã³ãŒã«ã®
ãã«ããŒã«ããšã¿ããŒã«ãããã©ãŒã«ãã¢ããã¢
ã»ã¿ãŒã«ãªã©ã®ã¢ã»ã¿ãŒã«èªå°äœãããªããã«ã¢
ã«ã³ãŒã«ã®é ¢é žãã®é žãé ªé žãã«ããã³é žãã©ãŠ
ãªã³é žãã¹ãã¢ãªã³é žãå®æ¯éŠé žãªã©ã®ãšã¹ãã«
èªå°äœããšãã¬ã³ã°ãªã³ãŒã«ããããã¬ã³ã°ãªã³
ãŒã«ãããã¬ã³ã°ãªã³ãŒã«ããžãšãã¬ã³ã°ãªã³ãŒ
ã«ãã·ã¯ããããµã³ãžãªãŒã«ããã³ã¿ãšãªã¹ãªã
ãŒã«ãã°ãªã»ãªã³ãïŒïŒïŒïŒïŒâããªã¡ãããŒã«
ãããã³ãªã©ã®ããªãªãŒã«ããã³ãã®ã«ã«ããã·
ã¡ãã«åç©ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãã
ãã¬ã³ã°ãªã³ãŒã«ãããªããã©ã¡ãã¬ã³ã°ãªã³ãŒ
ã«ãããªãšãã¬ã³âããªãããã¬ã³ã°ãªã³ãŒã«ãª
ã©ã®ããªãšãŒãã«ããªãªãŒã«ããã³ãã®ã«ã«ãã
ã·ã¡ãã«åç©ãã³ãã¯é žãã°ã«ã¿ã«é žãã¢ãžãã³
é žãã»ãã·ã³é žãã€ãœãã¿ã«é žããã¿ã«é žããã¬
ãã¿ã«é žãªã©ã®ãžã«ã«ãã³é žãšãšãã¬ã³ã°ãªã³ãŒ
ã«ããããã¬ã³ã°ãªã³ãŒã«ãããã¬ã³ã°ãªã³ãŒã«
ãªã©ã®ã°ãªã³ãŒã«ãšã®çž®åã«ãã€ãŠåŸãããäž¡æ«
端ã«æ°Žé žåºãæããããªãšã¹ãã«ããã³ãã®ã«ã«
ããã·ã¡ãã«åç©ãã§ãã¶ãããŒã©ãã³ãããã¹
ãã©ã³ãªã©ã®å€©ç¶é«ååããã³ãã®ã«ã«ããã·ã¡
ãã«åç©ãããªã¢ãã³ãªã©ãããããããããªã¢
ãã³ãšããŠã¯ãäŸãã°äœååããªã¢ãã³ãšããŠãš
ãã¬ã³ãžã¢ãã³ãããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒ
âãžã¢ãããããã³ãããã©ã¡ãã¬ã³ãžã¢ãã³ã
ïŒïŒïŒâãžã¢ãããã¿ã³ãïŒïŒïŒâãžã¢ãããã¿
ã³ããã³ã¿ã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ãã
ãã³ã¿ã³ããããµã¡ãã¬ã³ãžã¢ãã³ããªã¯ã¿ã¡ã
ã¬ã³ãžã¢ãã³ãããã¡ãã¬ã³ãžã¢ãã³ããã«ã¡ã
ã¬ã³ãžã¢ãã³ããŠã³ãã«ã¡ãã¬ã³ãžã¢ãã³ããã
ã«ã¡ãã¬ã³ãžã¢ãã³ãããªãã«ã¡ãã¬ã³ãžã¢ã
ã³ããªã¯ã¿ãã«ã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡
ãã«ãšãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžãšãã«ããªã¡
ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«ããªã¡ãã¬ã³
ãžã¢ãã³ãïŒïŒ®âãžããã«ããªã¡ãã¬ã³ãžã¢ã
ã³ãïŒïŒ®ïŒNâ²âããªãšãã«ãšãã¬ã³ãžã¢ãã³ã
âã¡ãã«ããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡
ãã«âïœâããšãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ã
ã«ãããµã¡ãã¬ã³ãžã¢ãã³ããžãšãã¬ã³ããªã¢ã
ã³ãããªãšãã¬ã³ããã©ãã³ãããã©ãšãã¬ã³ã
ã³ã¿ãã³ãããã¿ãšãã¬ã³ãªã¯ã¿ãã³ããããšã
ã¬ã³ãã«ãã³ãïŒïŒïŒâãã¹ïŒ2â²âã¢ãããšãã«
ã¢ããïŒãããã³ããã¹ïŒ3â²âã¢ãããããã«ïŒ
ã¢ãã³ãïŒïŒïŒâãã¹ïŒ3â²âã¢ãããããã«ã¢ã
ãïŒãããã³ãïŒïŒ23âããªã¢ãããããã³ãã
ãªã¹ïŒïŒâã¢ãããšãã«ïŒã¢ãã³ãããã©ïŒã¢ã
ãã¡ãã«ïŒã¡ã¿ã³ãã¡ãã«ã€ãããã¹ãããã«ã¢
ãã³ãã¡ãã«ã€ãããã¹ãšãã«ã¢ãã³ããšãã«ã€
ãããã¹ãšãã«ã¢ãã³ãâã¢ãããããã«âïŒ
ã¢ã«ããªã³ãâã¢ãããããã«âïŒâããã³ãª
ã³ãâïŒïŒâããããã·ãšãã«ïŒããªã¡ãã¬ã³
ãžã¢ãã³ããã·ãªã¬ã³ãžã¢ãã³ãããšãã¬ã³ãžã¢
ãã³ãããã©ãžã³ãâã¡ãã«ããã©ãžã³ãâ
ïŒïŒâã¢ãããšãã«ïŒãšã¿ããŒã«ã¢ãã³ãâã¢
ãããšãã«ããã©ãžã³ãïŒïŒ®ïŒNâ²ïŒNâ²âãã
ã©ã¡ãã«ãšãã¬ã³ãžã¢ãã³ãïŒïŒ®ïŒNâ²ïŒNâ²â
ããã©ã¡ãã«ããã©ã¡ãã¬ã³ãžã¢ãã³ãªã©ããã
ãããé«ååããªã¢ãã³ãšããŠ(i)ã¢ãã³ãšã¢ã«ã
ã¬ã³ãžãã©ã€ããããã¯ãšãã¯ãã«ãããªã³ãã
åæãããããªïŒã¢ã«ãã¬ã³ããªã¢ãã³ïŒããšã³
ãµã€ã¯ãããã€ã¢ ãªã ããªã㌠ãµã€ãšã³ã¹
ã¢ã³ã ãã¯ãããžãŒïŒïŒEncyclopedia of
Polymer Science and TechnologyïŒ10å·»ïŒ616
é ãïŒ(ii)ãšãã¬ã³ã€ãã³ããããã¬ã³ã€ãã³ãªã©
ã®ã¢ã«ãã¬ã³ã€ãã³ã®éç°éåã«ãã€ãŠåŸããã
ã¢ã«ãã¬ã³ã€ãã³éåäœããšã³ãµã€ã¯ãããã€ã¢
ãªã ããªã㌠ãµã€ãšã³ã¹ ã¢ã³ã ãã¯ã
ããžãŒïŒïŒå·»ïŒ734é ãã(iii)ãã®ä»ããªããã«ã¢ã
ã³ãããªãªãžã³ãªã©ãããããããããããã®ã
ãªã¢ãã³ã®ãã¡ã§ã¯ããªãšãã¬ã³ã€ãã³ã¯å®äŸ¡ã§
ãã€å€æ°ã®NH2åºãæã¡å¹æçã§ããã®ã§ç¹ã«
奜é©ã«çšããããã
çšããããååç©ãšããŠã¯ãäŸãã°ã°ã«ã¿ã«ã¢ã«
ãããããã¬ãã¿ã«ã¢ã«ããããã€ãœãã¿ã«ã¢ã«
ãããããžã¢ã«ãããã§ãã·ããªã©ã®ããªã¢ã«ã
ããããããµã¡ãã¬ã³ãžã€ãœã·ã¢ããŒãããã«ãš
ã³ãžã€ãœã·ã¢ããŒãããã·ã¬ã³ãžã€ãœã·ã¢ããŒ
ããããšãã¬ã³ãžã€ãœã·ã¢ããŒããã¢ããªã³âã
ã«ã ã¢ã«ãããã®ã€ãœã·ã¢ããŒãèªå°äœãªã©ã®ã
ãªã€ãœã·ã¢ããŒããå¡©åã¢ãžãã€ã«ãå¡©åã€ãœã
ã¿ãã€ã«ãå¡©åãã¬ãã¿ããŒã«ãå¡©åã·ã¢ãã«ãª
ã©ã®é žå¡©åç©ããããµã¡ãã¬ã³ããªã€ãœã·ã¢ããŒ
ããªã©ã®ããªããªã€ãœã·ã¢ããŒããïŒNâ²âãš
ãã¬ã³ãã¹ãšãŒãã¢ã»ãã¢ãããªã©ã®ïŒ®ïŒNâ²â
ããªã¡ãã¬ã³ãã¹ãšãŒãã¢ã»ãã¢ãããããã©ã¡
ãã¬ã³ã°ãªã³ãŒã«ãã°ãªã·ãžã«ãšãŒãã«ããžãšã
ã¬ã³ã°ãªã³ãŒã«ã®ãžã°ãªã·ãžã«ãšãŒãã«ãªã©ã®ã
ãªãšããã·ããããªç¡æ°Žãã¬ã€ã³é žãããªã€ã¿ã³
ã³é žç¡æ°Žç©ãç¡æ°Žãã¬ã€ã³é žâãã¿ã³ãžãªãŒã«ãž
ããã«ãšãŒãã«å ±éåäœãç¡æ°Žãã¬ã€ã³é žâããª
ãããã¬ã³ã°ã©ããå ±éåäœãç¡æ°Žãã¬ã€ã³é žâ
ã¡ãã«ããã«ãšãŒãã«å ±éåäœãç¡æ°Žãã¬ã€ã³é ž
âãšãã¬ã³å ±éåäœãç¡æ°Žãã¬ã€ã³é žâã¹ãã¬ã³
å ±éåäœãªã©ã®ããªã«ã«ãã³é žç¡æ°Žç©ãïŒ
Nâ²âãšãã¬ã³ãã¹ãã¬ã€ãããªã©ã®ãã¹ãã¬ã€
ãããïŒNâ²âã¡ãã¬ã³ãã¹ïŒã¡ã¿ïŒã¢ã¯ãªã«
ã¢ãããïŒNâ²âãããµã¡ãã¬ã³ãã¹ïŒã¡ã¿ïŒ
ã¢ã¯ãªã«ã¢ãããïŒNâ²ïŒNâ³âããªã¢ã¯ãªãã€
ã«ãããµãããããªã¢ãžã³ãªã©ã®ããªïŒã¡ã¿ïŒã¢
ã¯ãªãã€ã«ååç©ãã¢ã«ã®ã³é žããã¯ãã«é žãã¢
ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žããã¬ã€ã³é žãããã«
é žãã€ã¿ã³ã³é žãã¢ã¹ãã©ã®ã³é žãã°ã«ã¿ãã³é ž
ãªã©ã®ãã¢ããªããŒãããã¯ã³ããªããŒãããã¯
ãããã®é žãšã¡ãã«ããšãã«ããããã«ããã
ã«ãã¢ãã«ãããã·ã«ããªã¯ãã«ãããã·ã«ãªã©
ãšã®ã¢ã«ãã«ãšã¹ãã«ãã¯ãã«ã¡ãã«ãïŒâã¯ã
ã«ãšãã«ãïŒâããã ãšãã«ãªã©ãšã®ããã²ã³å
ã¢ã«ãã«ãšã¹ãã«ãïŒâãšããã·ãšãã«ãïŒâã
ããã·ãšãã«ãïŒâïŒïŒâãšããã·ã¡ããã·ïŒãš
ãã«ãããšããã·ãšãã«ãã°ãªã·ãžã«ãªã©ãšãŒã
ã«åºãæãããã®ãšã®ãšã¹ãã«ãïŒâã¢ãããšã
ã«ãïŒâïŒNâ²âãžã¡ãã«ã¢ãããšãã«ãïŒâ
ïŒNâ²âãžãšãã«ã¢ãããšãã«ãïŒâïŒNâ²â
ãžãããã«ã¢ãããšãã«ãªã©å¡©åºæ§çªçŽ ãæãã
ãã®ãšã®ãšã¹ãã«ããšãã¬ã³ã°ãªã³ãŒã«ããžãšã
ã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããª
ãšãã¬ã³ã°ãªã³ãŒã«ãªã©ãšã®ã¢ããšã¹ãã«ããã
ã¯ãžãšã¹ãã«ãªã©ããããããããã«ã¯ã¢ã»ãã«
ã»ã«ããŒã¹ãããããªã³é žã»ã«ããŒã¹ãé ªé žã»ã«
ããŒã¹ããããã»ã«ããŒã¹ãé ¢é žã»ã«ããŒã¹ããª
ã³é žã»ã«ããŒã¹ããžããªã«ã«ãã³é žã»ã«ããŒã¹ãª
ã©ã®ã»ã«ããŒã¹ã®ãšã¹ãã«åèªå°äœãã¡ãã«ã»ã«
ããŒã¹ããšãã«ã»ã«ããŒã¹ããã³ãžã«ã»ã«ããŒ
ã¹ãããªã¡ãã«ã»ã«ããŒã¹ãã·ã¢ããšãã«ã»ã«ã
ãŒã¹ãã¢ãããšãã«ã»ã«ããŒã¹ããªãã·ãšãã«ã»
ã«ããŒã¹ãªã©ã®ã»ã«ããŒã¹ã®ãšãŒãã«åèªå°äœã
ããªããã«ã¢ã«ã³ãŒã«ãããªããã«ã¢ã«ã³ãŒã«ãš
ãšãã¬ã³ããããã¬ã³ãå¡©åããã«ãã¢ãªã«ã¢ã«
ã³ãŒã«ãâããã«ãããªãã³ãªã©ãšã®å ±éå
äœãããªããã«ã¢ã«ã³ãŒã«ã®ã¡ãã«ããšãã«ãã
ããã«ãããã«ããªã¯ãã«ãããã·ã«ãããšãã«
ãªã©ã®ãšãŒãã«èªå°äœãããªããã«ã¢ã«ã³ãŒã«ã®
ãã«ããŒã«ããšã¿ããŒã«ãããã©ãŒã«ãã¢ããã¢
ã»ã¿ãŒã«ãªã©ã®ã¢ã»ã¿ãŒã«èªå°äœãããªããã«ã¢
ã«ã³ãŒã«ã®é ¢é žãã®é žãé ªé žãã«ããã³é žãã©ãŠ
ãªã³é žãã¹ãã¢ãªã³é žãå®æ¯éŠé žãªã©ã®ãšã¹ãã«
èªå°äœããšãã¬ã³ã°ãªã³ãŒã«ããããã¬ã³ã°ãªã³
ãŒã«ãããã¬ã³ã°ãªã³ãŒã«ããžãšãã¬ã³ã°ãªã³ãŒ
ã«ãã·ã¯ããããµã³ãžãªãŒã«ããã³ã¿ãšãªã¹ãªã
ãŒã«ãã°ãªã»ãªã³ãïŒïŒïŒïŒïŒâããªã¡ãããŒã«
ãããã³ãªã©ã®ããªãªãŒã«ããã³ãã®ã«ã«ããã·
ã¡ãã«åç©ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãã
ãã¬ã³ã°ãªã³ãŒã«ãããªããã©ã¡ãã¬ã³ã°ãªã³ãŒ
ã«ãããªãšãã¬ã³âããªãããã¬ã³ã°ãªã³ãŒã«ãª
ã©ã®ããªãšãŒãã«ããªãªãŒã«ããã³ãã®ã«ã«ãã
ã·ã¡ãã«åç©ãã³ãã¯é žãã°ã«ã¿ã«é žãã¢ãžãã³
é žãã»ãã·ã³é žãã€ãœãã¿ã«é žããã¿ã«é žããã¬
ãã¿ã«é žãªã©ã®ãžã«ã«ãã³é žãšãšãã¬ã³ã°ãªã³ãŒ
ã«ããããã¬ã³ã°ãªã³ãŒã«ãããã¬ã³ã°ãªã³ãŒã«
ãªã©ã®ã°ãªã³ãŒã«ãšã®çž®åã«ãã€ãŠåŸãããäž¡æ«
端ã«æ°Žé žåºãæããããªãšã¹ãã«ããã³ãã®ã«ã«
ããã·ã¡ãã«åç©ãã§ãã¶ãããŒã©ãã³ãããã¹
ãã©ã³ãªã©ã®å€©ç¶é«ååããã³ãã®ã«ã«ããã·ã¡
ãã«åç©ãããªã¢ãã³ãªã©ãããããããããªã¢
ãã³ãšããŠã¯ãäŸãã°äœååããªã¢ãã³ãšããŠãš
ãã¬ã³ãžã¢ãã³ãããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒ
âãžã¢ãããããã³ãããã©ã¡ãã¬ã³ãžã¢ãã³ã
ïŒïŒïŒâãžã¢ãããã¿ã³ãïŒïŒïŒâãžã¢ãããã¿
ã³ããã³ã¿ã¡ãã¬ã³ãžã¢ãã³ãïŒïŒïŒâãžã¢ãã
ãã³ã¿ã³ããããµã¡ãã¬ã³ãžã¢ãã³ããªã¯ã¿ã¡ã
ã¬ã³ãžã¢ãã³ãããã¡ãã¬ã³ãžã¢ãã³ããã«ã¡ã
ã¬ã³ãžã¢ãã³ããŠã³ãã«ã¡ãã¬ã³ãžã¢ãã³ããã
ã«ã¡ãã¬ã³ãžã¢ãã³ãããªãã«ã¡ãã¬ã³ãžã¢ã
ã³ããªã¯ã¿ãã«ã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡
ãã«ãšãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžãšãã«ããªã¡
ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ãã«ããªã¡ãã¬ã³
ãžã¢ãã³ãïŒïŒ®âãžããã«ããªã¡ãã¬ã³ãžã¢ã
ã³ãïŒïŒ®ïŒNâ²âããªãšãã«ãšãã¬ã³ãžã¢ãã³ã
âã¡ãã«ããªã¡ãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡
ãã«âïœâããšãã¬ã³ãžã¢ãã³ãïŒïŒ®âãžã¡ã
ã«ãããµã¡ãã¬ã³ãžã¢ãã³ããžãšãã¬ã³ããªã¢ã
ã³ãããªãšãã¬ã³ããã©ãã³ãããã©ãšãã¬ã³ã
ã³ã¿ãã³ãããã¿ãšãã¬ã³ãªã¯ã¿ãã³ããããšã
ã¬ã³ãã«ãã³ãïŒïŒïŒâãã¹ïŒ2â²âã¢ãããšãã«
ã¢ããïŒãããã³ããã¹ïŒ3â²âã¢ãããããã«ïŒ
ã¢ãã³ãïŒïŒïŒâãã¹ïŒ3â²âã¢ãããããã«ã¢ã
ãïŒãããã³ãïŒïŒ23âããªã¢ãããããã³ãã
ãªã¹ïŒïŒâã¢ãããšãã«ïŒã¢ãã³ãããã©ïŒã¢ã
ãã¡ãã«ïŒã¡ã¿ã³ãã¡ãã«ã€ãããã¹ãããã«ã¢
ãã³ãã¡ãã«ã€ãããã¹ãšãã«ã¢ãã³ããšãã«ã€
ãããã¹ãšãã«ã¢ãã³ãâã¢ãããããã«âïŒ
ã¢ã«ããªã³ãâã¢ãããããã«âïŒâããã³ãª
ã³ãâïŒïŒâããããã·ãšãã«ïŒããªã¡ãã¬ã³
ãžã¢ãã³ããã·ãªã¬ã³ãžã¢ãã³ãããšãã¬ã³ãžã¢
ãã³ãããã©ãžã³ãâã¡ãã«ããã©ãžã³ãâ
ïŒïŒâã¢ãããšãã«ïŒãšã¿ããŒã«ã¢ãã³ãâã¢
ãããšãã«ããã©ãžã³ãïŒïŒ®ïŒNâ²ïŒNâ²âãã
ã©ã¡ãã«ãšãã¬ã³ãžã¢ãã³ãïŒïŒ®ïŒNâ²ïŒNâ²â
ããã©ã¡ãã«ããã©ã¡ãã¬ã³ãžã¢ãã³ãªã©ããã
ãããé«ååããªã¢ãã³ãšããŠ(i)ã¢ãã³ãšã¢ã«ã
ã¬ã³ãžãã©ã€ããããã¯ãšãã¯ãã«ãããªã³ãã
åæãããããªïŒã¢ã«ãã¬ã³ããªã¢ãã³ïŒããšã³
ãµã€ã¯ãããã€ã¢ ãªã ããªã㌠ãµã€ãšã³ã¹
ã¢ã³ã ãã¯ãããžãŒïŒïŒEncyclopedia of
Polymer Science and TechnologyïŒ10å·»ïŒ616
é ãïŒ(ii)ãšãã¬ã³ã€ãã³ããããã¬ã³ã€ãã³ãªã©
ã®ã¢ã«ãã¬ã³ã€ãã³ã®éç°éåã«ãã€ãŠåŸããã
ã¢ã«ãã¬ã³ã€ãã³éåäœããšã³ãµã€ã¯ãããã€ã¢
ãªã ããªã㌠ãµã€ãšã³ã¹ ã¢ã³ã ãã¯ã
ããžãŒïŒïŒå·»ïŒ734é ãã(iii)ãã®ä»ããªããã«ã¢ã
ã³ãããªãªãžã³ãªã©ãããããããããããã®ã
ãªã¢ãã³ã®ãã¡ã§ã¯ããªãšãã¬ã³ã€ãã³ã¯å®äŸ¡ã§
ãã€å€æ°ã®NH2åºãæã¡å¹æçã§ããã®ã§ç¹ã«
奜é©ã«çšããããã
(2)ããã³(3)ã®æ¹æ³ã«ãããŠã¯åè¿°ã®ã³ãŒãã€ã³
ã°çšååç©ãé©åœãªæº¶åªã«æº¶è§£ããŠçšããããã
ããã¯ããèªäœã液äœã§ããå Žåã¯ãã®ãŸãŸçšã
ãŠæµžæŒ¬æ³ãå¹ãã€ãæ³ãã¯ãã¬ãæ³ãªã©ã®å ¬ç¥ã®
æ¹æ³ã§ã³ãŒãã€ã³ã°ããããã³ãŒãã€ã³ã°ã«éã
ãŠã³ãŒãã€ã³ã°çšååç©ã¯åç¬ã§çšããŠããã
ããæ··åããŠçšããŠããããã³ãŒãã€ã³ã°å±€ãè€
æ°ã«ããããšã¯ç¹ã«(2)ã®æ¹æ³ã«ãããŠå¥œãŸããæ¡
çšããããäŸãã°é žæ§ã®åå¿æ§å®èœåºã®ã¿ãéç
ã«ãäžå åã«å°å ¥ãããŠããå°å°¿ã«ããŒãã«ã«ã
é°ã€ãªã³äº€æåºã®ã¿ãæã€æçç©è³ªãå€éã«ã€ãª
ã³çµåããããå Žåãäžããå¡©åºæ§ã®å®èœåºãé
çã«å åæã€ååç©ãäŸãã°ããªãšãã¬ã³ã€ãã³
ãã³ãŒãã€ã³ã°ããŠãããããã«ãã®äžã«é žæ§ã®
åå¿æ§å®èœåºãéå°ã«ãã€ååç©ãäŸãã°ç¡æ°Žã
ã¬ã€ã³é žå ±éåäœãã³ãŒãã€ã³ã°ããããã®åŸã«
åå¿æ§å®èœåºãã€ãªã³åããŠéœã€ãªã³äº€æåºãåŸ
ãŠãæçç©è³ªã®é°ã€ãªã³äº€æåºãšã®éã«ã€ãªã³çµ
åã圢æãããããšã«ãã€ãŠç®çãéããããã
ãŸããã³ãŒãã€ã³ã°çšååç©ãšæ··åããŠçšããã
ãšã¯ç¹ã«(3)ã®æ¹æ³ã«ãããŠå¥œãŸããæ¡çšãããã
ãã®å Žåã«ã¯æ··åãããååç©åå¿ã®æ¶æ©ãªã©ã«
ããã³ãŒãã€ã³ã°å±€ã®åŒ·åã察尿äžæº¶åå¹æãæ
åŸ ã§ããããã§ãå ·äœçã«ã¯ããªã¢ã«ããããã
ãªã€ãœã·ã¢ããŒããé žå¡©åç©ãããªããªã€ãœã·ã¢
ããŒããïŒNâ²âããªã¡ãã¬ã³ãã¹ãšãŒããã¢
ã»ãã¢ãããããªãšããã·ããããªã«ã«ãã³é žç¡
æ°Žç©ããã¹ãã¬ã€ããããªïŒã¡ã¿ïŒã¢ã¯ãªãã€ã«
ååç©ãªã©ãšãããªã¢ãã³ãããªãªãŒã«ãããªãª
ãŒã«ã®ã«ã«ããã·ã¡ãã«åç©ãªã©ãšãæ··åããŠã³
ãŒãã€ã³ã°ããå°å°¿ã«ããŒãã«å£é¢äžã§åå¿ãã
ãããããã¯æ··åãããåã«äžèšååç©çŸ€ã®ã©ã¡
ããããéžã°ããïŒçš®ããããããå°å°¿ã«ããŒã
ã«ã«åžçãããåŸã«ä»ã®çŸ€ããéžã°ããïŒçš®ãå
ããŠåå¿ããããšãã€ãæ¹æ³ãæ¡çšãããããªã
ã§ãç¡æ°Žãã¬ã€ã³é žå ±éåäœãšããªããã«ã¢ã«ã³
ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã€
ãã³ãªã©ãšã®çµã¿åããããã®äžæº¶æ§ãçäœé©å
æ§ãæçç©è³ªãšã®ã€ãªã³çµå圢ææ§ãªã©ããç¹ã«
奜ãŸãã䜿çšãããã
ã°çšååç©ãé©åœãªæº¶åªã«æº¶è§£ããŠçšããããã
ããã¯ããèªäœã液äœã§ããå Žåã¯ãã®ãŸãŸçšã
ãŠæµžæŒ¬æ³ãå¹ãã€ãæ³ãã¯ãã¬ãæ³ãªã©ã®å ¬ç¥ã®
æ¹æ³ã§ã³ãŒãã€ã³ã°ããããã³ãŒãã€ã³ã°ã«éã
ãŠã³ãŒãã€ã³ã°çšååç©ã¯åç¬ã§çšããŠããã
ããæ··åããŠçšããŠããããã³ãŒãã€ã³ã°å±€ãè€
æ°ã«ããããšã¯ç¹ã«(2)ã®æ¹æ³ã«ãããŠå¥œãŸããæ¡
çšããããäŸãã°é žæ§ã®åå¿æ§å®èœåºã®ã¿ãéç
ã«ãäžå åã«å°å ¥ãããŠããå°å°¿ã«ããŒãã«ã«ã
é°ã€ãªã³äº€æåºã®ã¿ãæã€æçç©è³ªãå€éã«ã€ãª
ã³çµåããããå Žåãäžããå¡©åºæ§ã®å®èœåºãé
çã«å åæã€ååç©ãäŸãã°ããªãšãã¬ã³ã€ãã³
ãã³ãŒãã€ã³ã°ããŠãããããã«ãã®äžã«é žæ§ã®
åå¿æ§å®èœåºãéå°ã«ãã€ååç©ãäŸãã°ç¡æ°Žã
ã¬ã€ã³é žå ±éåäœãã³ãŒãã€ã³ã°ããããã®åŸã«
åå¿æ§å®èœåºãã€ãªã³åããŠéœã€ãªã³äº€æåºãåŸ
ãŠãæçç©è³ªã®é°ã€ãªã³äº€æåºãšã®éã«ã€ãªã³çµ
åã圢æãããããšã«ãã€ãŠç®çãéããããã
ãŸããã³ãŒãã€ã³ã°çšååç©ãšæ··åããŠçšããã
ãšã¯ç¹ã«(3)ã®æ¹æ³ã«ãããŠå¥œãŸããæ¡çšãããã
ãã®å Žåã«ã¯æ··åãããååç©åå¿ã®æ¶æ©ãªã©ã«
ããã³ãŒãã€ã³ã°å±€ã®åŒ·åã察尿äžæº¶åå¹æãæ
åŸ ã§ããããã§ãå ·äœçã«ã¯ããªã¢ã«ããããã
ãªã€ãœã·ã¢ããŒããé žå¡©åç©ãããªããªã€ãœã·ã¢
ããŒããïŒNâ²âããªã¡ãã¬ã³ãã¹ãšãŒããã¢
ã»ãã¢ãããããªãšããã·ããããªã«ã«ãã³é žç¡
æ°Žç©ããã¹ãã¬ã€ããããªïŒã¡ã¿ïŒã¢ã¯ãªãã€ã«
ååç©ãªã©ãšãããªã¢ãã³ãããªãªãŒã«ãããªãª
ãŒã«ã®ã«ã«ããã·ã¡ãã«åç©ãªã©ãšãæ··åããŠã³
ãŒãã€ã³ã°ããå°å°¿ã«ããŒãã«å£é¢äžã§åå¿ãã
ãããããã¯æ··åãããåã«äžèšååç©çŸ€ã®ã©ã¡
ããããéžã°ããïŒçš®ããããããå°å°¿ã«ããŒã
ã«ã«åžçãããåŸã«ä»ã®çŸ€ããéžã°ããïŒçš®ãå
ããŠåå¿ããããšãã€ãæ¹æ³ãæ¡çšãããããªã
ã§ãç¡æ°Žãã¬ã€ã³é žå ±éåäœãšããªããã«ã¢ã«ã³
ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãšãã¬ã³ã€
ãã³ãªã©ãšã®çµã¿åããããã®äžæº¶æ§ãçäœé©å
æ§ãæçç©è³ªãšã®ã€ãªã³çµå圢ææ§ãªã©ããç¹ã«
奜ãŸãã䜿çšãããã
ã³ãŒãã€ã³ã°ã«éããŠçšãã溶åªã¯ã³ãŒãã€ã³
ã°çšååç©ã溶解ãããã€å°å°¿ã«ããŒãã«çŽ æã
䟵é£ããªããã®ã§ããã°ãããªããã®ã§ããã
ããã³ãŒãã€ã³ã°ã«éããŠå°å°¿ã«ããŒãã«çŽ æã
èšæœ€ããããã€æº¶åªèžçºåŸã¯çŽ æã®åŒ·åºŠã寞æ³å®
å®æ§ãç¯ããªããããªæº¶åªïŒäŸãã°å€©ç¶ãŽã ã«å¯Ÿ
ããŠã®ããã©ããã©ãã©ã³âæ°Žã®æ··å溶åªïŒã¯å¹
ççãªã³ãŒãã€ã³ã°ã«ãšã€ãŠéåžžã«æå¹ã§ããã
ã°çšååç©ã溶解ãããã€å°å°¿ã«ããŒãã«çŽ æã
䟵é£ããªããã®ã§ããã°ãããªããã®ã§ããã
ããã³ãŒãã€ã³ã°ã«éããŠå°å°¿ã«ããŒãã«çŽ æã
èšæœ€ããããã€æº¶åªèžçºåŸã¯çŽ æã®åŒ·åºŠã寞æ³å®
å®æ§ãç¯ããªããããªæº¶åªïŒäŸãã°å€©ç¶ãŽã ã«å¯Ÿ
ããŠã®ããã©ããã©ãã©ã³âæ°Žã®æ··å溶åªïŒã¯å¹
ççãªã³ãŒãã€ã³ã°ã«ãšã€ãŠéåžžã«æå¹ã§ããã
(2)ã®æ¹æ³ã§ã³ãŒãã€ã³ã°ãããå±€ã¯å°¿ã«å¯ŸããŠ
å®å šã«äžæº¶ã§ãå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£
å šé¢ã«å ±æçµåããŠä¿æãããŠãããäœå ç眮äž
ã«å°¿äžã«æµãåºãããã¯ããããããããšã¯ãªã
ãã(3)ã®æ¹æ³ã§è¡ãæã«ã¯ã³ãŒãã€ã³ã°ã«äœ¿çšã
ãååç©ããã³å°å°¿ã«ããŒãã«ã®çŽ æã«ãã€ãŠ
ã¯ãå¿ èŠã«å¿ãæ¥çå±€ãèšããããã³ãŒãã€ã³ã°
çšååç©ã«æ¥çå€ãæ··å ¥ããŠçšãããããããšã
æãŸããã
å®å šã«äžæº¶ã§ãå°å°¿ã«ããŒãã«ã®å å£ãŸãã¯å€å£
å šé¢ã«å ±æçµåããŠä¿æãããŠãããäœå ç眮äž
ã«å°¿äžã«æµãåºãããã¯ããããããããšã¯ãªã
ãã(3)ã®æ¹æ³ã§è¡ãæã«ã¯ã³ãŒãã€ã³ã°ã«äœ¿çšã
ãååç©ããã³å°å°¿ã«ããŒãã«ã®çŽ æã«ãã€ãŠ
ã¯ãå¿ èŠã«å¿ãæ¥çå±€ãèšããããã³ãŒãã€ã³ã°
çšååç©ã«æ¥çå€ãæ··å ¥ããŠçšãããããããšã
æãŸããã
æçç©è³ªãã€ãªã³çµåãããã«ããã€ãŠã¯ãæ
çç©è³ªã®æº¶æ¶²ãã¹ãã¬ãŒããæ¹æ³ãå°å°¿ã«ããŒã
ã«å ã«æçç©è³ªã®æº¶æ¶²ã埪ç°ãããæ¹æ³ãªã©ãçš
ããããããæã簡䟿ãªæ¹æ³ã¯å°å°¿ã«ããŒãã«ã
æçç©è³ªã®æº¶æ¶²ã«æµžæŒ¬ããæ¹æ³ã§ãããäžè¬ã«å¹
ççã«ã€ãªã³çµåãè¡ãããããã«ã¯æçç©è³ªã®
溶液ã®PHã奜é©ãªç¯å²ã«èª¿æŽããããšãæãŸã
ããããšãã°é°ã€ãªã³äº€æåºãæã€æçç©è³ªã®å Ž
åã¯æçç©è³ªã®æº¶æ¶²ãã¢ã«ã«ãªæ§ã«ãéœã€ãªã³äº€
æåºãæã€æçç©è³ªã®å Žåã¯é žæ§ã«ä¿ã€ãç¶æ ã«
ãŠè¡ãããšã«ããå¹ççãªã€ãªã³çµåãåŸããã
ããšãå€ãããã®ããšã¯äŸãã°ã€ãªã³çµååå¿é²
è¡äžã«é žãããã¯ã¢ã«ã«ãªãåžžæ滎äžããããšãª
ã©ã«ããéæãããã
çç©è³ªã®æº¶æ¶²ãã¹ãã¬ãŒããæ¹æ³ãå°å°¿ã«ããŒã
ã«å ã«æçç©è³ªã®æº¶æ¶²ã埪ç°ãããæ¹æ³ãªã©ãçš
ããããããæã簡䟿ãªæ¹æ³ã¯å°å°¿ã«ããŒãã«ã
æçç©è³ªã®æº¶æ¶²ã«æµžæŒ¬ããæ¹æ³ã§ãããäžè¬ã«å¹
ççã«ã€ãªã³çµåãè¡ãããããã«ã¯æçç©è³ªã®
溶液ã®PHã奜é©ãªç¯å²ã«èª¿æŽããããšãæãŸã
ããããšãã°é°ã€ãªã³äº€æåºãæã€æçç©è³ªã®å Ž
åã¯æçç©è³ªã®æº¶æ¶²ãã¢ã«ã«ãªæ§ã«ãéœã€ãªã³äº€
æåºãæã€æçç©è³ªã®å Žåã¯é žæ§ã«ä¿ã€ãç¶æ ã«
ãŠè¡ãããšã«ããå¹ççãªã€ãªã³çµåãåŸããã
ããšãå€ãããã®ããšã¯äŸãã°ã€ãªã³çµååå¿é²
è¡äžã«é žãããã¯ã¢ã«ã«ãªãåžžæ滎äžããããšãª
ã©ã«ããéæãããã
æ¬çºæã®å°å°¿ã«ããŒãã«ã¯ãåèš(1)ïŒ(2)ïŒ(3)ã®
ã©ã®æ¹æ³ã§åŸãããã«ããåæ§ã®ææé²æ¢èœåã
é·æéæãããã®ã§ãããã(1)ã®æ¹æ³ã§ã¯ã³ãŒã
ã€ã³ã°ã®æäœãäžå¿ èŠã§ãããã補é å·¥çšãç°¡ç¥
ã§ããã(2)ã®æ¹æ³ã§ã¯ä»»æã®æçç©è³ªãå€éã«ã€
ãªã³çµåãããããšãå¯èœã§ããããŸãã³ãŒãã€
ã³ã°å±€ã®å°å°¿ã«ããŒãã«ãžã®æ¥çæ§ãè¯ãã(3)ã®
æ¹æ³ã§ã¯åå¿æ§å®èœåºãå°å ¥ããå¿ èŠããªãã®
ã§ãå°å ¥åå¿ã«ãããŠå°å°¿ã«ããŒãã«ã®åŒ·åºŠã䌞
床ãªã©ã®è«žç©æ§ãæãå¯èœæ§ããªããéžé å·¥çšã
ç°¡ç¥ã§ãããä»»æã®æçç©è³ªãå€éã«ã€ãªã³çµå
ãããããšãå¯èœã§ãããããã«(2)ïŒ(3)ã®æ¹æ³ã®
å Žåã³ãŒãã€ã³ã°çšååç©ãšããŠãäŸãã°ããªã
ãã«ã¢ã«ã³ãŒã«ã®ã«ã«ããã·ã¡ãã«åç©ãªã©ã®ã
ããªèŠªæ°Žæ§ã®é«ããã®ãéžã¹ã°äœå ç眮æã®çã¿
ã軜æžããããšãã€ãå©ç¹ãããã
ã©ã®æ¹æ³ã§åŸãããã«ããåæ§ã®ææé²æ¢èœåã
é·æéæãããã®ã§ãããã(1)ã®æ¹æ³ã§ã¯ã³ãŒã
ã€ã³ã°ã®æäœãäžå¿ èŠã§ãããã補é å·¥çšãç°¡ç¥
ã§ããã(2)ã®æ¹æ³ã§ã¯ä»»æã®æçç©è³ªãå€éã«ã€
ãªã³çµåãããããšãå¯èœã§ããããŸãã³ãŒãã€
ã³ã°å±€ã®å°å°¿ã«ããŒãã«ãžã®æ¥çæ§ãè¯ãã(3)ã®
æ¹æ³ã§ã¯åå¿æ§å®èœåºãå°å ¥ããå¿ èŠããªãã®
ã§ãå°å ¥åå¿ã«ãããŠå°å°¿ã«ããŒãã«ã®åŒ·åºŠã䌞
床ãªã©ã®è«žç©æ§ãæãå¯èœæ§ããªããéžé å·¥çšã
ç°¡ç¥ã§ãããä»»æã®æçç©è³ªãå€éã«ã€ãªã³çµå
ãããããšãå¯èœã§ãããããã«(2)ïŒ(3)ã®æ¹æ³ã®
å Žåã³ãŒãã€ã³ã°çšååç©ãšããŠãäŸãã°ããªã
ãã«ã¢ã«ã³ãŒã«ã®ã«ã«ããã·ã¡ãã«åç©ãªã©ã®ã
ããªèŠªæ°Žæ§ã®é«ããã®ãéžã¹ã°äœå ç眮æã®çã¿
ã軜æžããããšãã€ãå©ç¹ãããã
以äžãå®æœäŸããããŠæ¬çºæãããã«å
·äœçã«
説æããããªããäŸäžã®ãéšãã¯ãéééšããæ
å³ããã
説æããããªããäŸäžã®ãéšãã¯ãéééšããæ
å³ããã
å®æœäŸ ïŒ
J.Le Brasãã®æ¹æ³ïŒã€ã³ãã¹ããªã¢ã« ã¢ã³
ã ãšã³ãžãã¢ãªã³ã° ã±ãã¹ããªãŒ ãããã¯
ããªãµãŒã ã¢ã³ã ãã€ããããã¡ã³ã第ïŒ
å·»ïŒ22é ïŒ1963ïŒããåç §ããŠã倩ç¶ãŽã ãšç¡æ°Ž
ãã¬ã€ã³é žãåå¿ãããã€ãœãã¬ã³åäœããã
5.2ã¢ã«ïŒ ã®é žç¡æ°Žç©åºãå°å ¥ããã倩ç¶ãŽã ã
åŸããã®ãã®ãææãšããŠå°å°¿ã«ããŒãã«ãæ圢
ãããåŸãããå°å°¿ã«ããŒãã«ã100âã®æ°Žäžã«
ïŒæé浞挬ããåŸãç¡«é žãžãã«ã·ã³æ°Žæº¶æ¶²ã50mg
ïŒã«äŸ¡ïŒïŒ100mlãã«ãPHã0.1Nã®æ°Žé žåãããª
ãŠã ãçšããŠïŒã«èª¿æŽããªããïŒâã«ãŠïŒæé浞
挬ãããã®å å€å£ã«ç¡«é žãžãã«ã·ã³ãã€ãªã³çµå
ãããå°å°¿ã«ããŒãã«ãåŸãã
ã ãšã³ãžãã¢ãªã³ã° ã±ãã¹ããªãŒ ãããã¯
ããªãµãŒã ã¢ã³ã ãã€ããããã¡ã³ã第ïŒ
å·»ïŒ22é ïŒ1963ïŒããåç §ããŠã倩ç¶ãŽã ãšç¡æ°Ž
ãã¬ã€ã³é žãåå¿ãããã€ãœãã¬ã³åäœããã
5.2ã¢ã«ïŒ ã®é žç¡æ°Žç©åºãå°å ¥ããã倩ç¶ãŽã ã
åŸããã®ãã®ãææãšããŠå°å°¿ã«ããŒãã«ãæ圢
ãããåŸãããå°å°¿ã«ããŒãã«ã100âã®æ°Žäžã«
ïŒæé浞挬ããåŸãç¡«é žãžãã«ã·ã³æ°Žæº¶æ¶²ã50mg
ïŒã«äŸ¡ïŒïŒ100mlãã«ãPHã0.1Nã®æ°Žé žåãããª
ãŠã ãçšããŠïŒã«èª¿æŽããªããïŒâã«ãŠïŒæé浞
挬ãããã®å å€å£ã«ç¡«é žãžãã«ã·ã³ãã€ãªã³çµå
ãããå°å°¿ã«ããŒãã«ãåŸãã
ãã®ãã®ãç¡èäžã§37âã®è©Šéšå°¿äžã«æµžæŒ¬ãã
ïŒæ¥çµéåŸãè©Šéšèã«Bacillus Subtilis
ATCC6633ãçšããŠåçå¹³æ¿æ³ã«ãŠåçå¹³æ¿ã«è©Š
éšå°¿ãïŒãïŒæ»Žèœäžãããããšã«ãããã®å°¿ã®æ
è掻æ§ãã¹ããè¡ã€ããšããé»æ¢åãçããè©Šéš
å°¿äžã«æŽ»æ§ãªæçç©è³ªãååšããããšã確èªãã
ããããã«è©Šéšå°¿ãïŒæ¥ããšã«æ°ããè©Šéšå°¿ã«å
ã代ããŠåæ§ã«æŽ»æ§ãã¹ããç¹°ãè¿ãè¡ã€ããšã
ãã30æ¥ç®ã«æ¡åããè©Šéšå°¿ã«ã€ããŠãé»æ¢åã
çã掻æ§ã確èªãããã
ïŒæ¥çµéåŸãè©Šéšèã«Bacillus Subtilis
ATCC6633ãçšããŠåçå¹³æ¿æ³ã«ãŠåçå¹³æ¿ã«è©Š
éšå°¿ãïŒãïŒæ»Žèœäžãããããšã«ãããã®å°¿ã®æ
è掻æ§ãã¹ããè¡ã€ããšããé»æ¢åãçããè©Šéš
å°¿äžã«æŽ»æ§ãªæçç©è³ªãååšããããšã確èªãã
ããããã«è©Šéšå°¿ãïŒæ¥ããšã«æ°ããè©Šéšå°¿ã«å
ã代ããŠåæ§ã«æŽ»æ§ãã¹ããç¹°ãè¿ãè¡ã€ããšã
ãã30æ¥ç®ã«æ¡åããè©Šéšå°¿ã«ã€ããŠãé»æ¢åã
çã掻æ§ã確èªãããã
æ¯èŒäŸ ïŒ
å®æœäŸïŒã§åŸãããé
žç¡æ°Žç©åºã®å°å
¥ãããå°
å°¿ã«ããŒãã«ãã100âã®ç±æ°ŽåŠçãæœãããšãª
ããå®æœäŸïŒãšåæ§ã«ããŠç¡«é žãžãã«ã·ã³æ°Žæº¶æ¶²
åŠçãè¡ã€ãã
å°¿ã«ããŒãã«ãã100âã®ç±æ°ŽåŠçãæœãããšãª
ããå®æœäŸïŒãšåæ§ã«ããŠç¡«é žãžãã«ã·ã³æ°Žæº¶æ¶²
åŠçãè¡ã€ãã
ãã®ããã«ããŠåŸãããå°å°¿ã«ããŒãã«ã«ã€ã
ãŠå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããé»
æ¢åã¯çããªãã€ãã
ãŠå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããé»
æ¢åã¯çããªãã€ãã
æ¯èŒäŸ ïŒïŒïŒ
å®æœäŸïŒã«ãŠäœ¿çšãã倩ç¶ãŽã ãçšããŠå°å°¿ã«
ããŒãã«ãæ圢ããå®æœäŸïŒãšåæ§ã«ããŠç¡«é žãž
ãã«ã·ã³æ°Žæº¶æ¶²åŠçãè¡ããã€ãã§å®æœäŸïŒãšå
æ§ã®æŽ»æ§ãã¹ããè¡ã€ããšãããïŒæ¥ç®ã«æ¡åã
ãè©Šéšå°¿ã«ã€ããŠã¯é»æ¢åãçããŠããªãã€ãã
ããŒãã«ãæ圢ããå®æœäŸïŒãšåæ§ã«ããŠç¡«é žãž
ãã«ã·ã³æ°Žæº¶æ¶²åŠçãè¡ããã€ãã§å®æœäŸïŒãšå
æ§ã®æŽ»æ§ãã¹ããè¡ã€ããšãããïŒæ¥ç®ã«æ¡åã
ãè©Šéšå°¿ã«ã€ããŠã¯é»æ¢åãçããŠããªãã€ãã
ãŸããå®æœäŸïŒã§åŸãããé
žç¡æ°Žç©åºã®å°å
¥ã
ããå°å°¿ã«ããŒãã«ã«ã€ããŠæçç©è³ªãã€ãªã³çµ
åããã以åã«ãå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ãã
è¡ã€ãããé»æ¢åã¯ïŒæ¥ç®ã®è©Šéšå°¿ã«ã€ããŠãèª
ããããªãã€ãã
ããå°å°¿ã«ããŒãã«ã«ã€ããŠæçç©è³ªãã€ãªã³çµ
åããã以åã«ãå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ãã
è¡ã€ãããé»æ¢åã¯ïŒæ¥ç®ã®è©Šéšå°¿ã«ã€ããŠãèª
ããããªãã€ãã
å®æœäŸ ïŒ
倩ç¶ãŽã å°å°¿ã«ããŒãã«ãã¢ãŒã¬ã€ã«ã»ããªãŒ
ãªãŒã»ã«ããŒãã«ïŒæ¥æ¬ã·ã€ãŒãŠãã(æ ª)補ã100
éšãã20éšã®ç¡æ°Žãã¬ã€ã³é žãš0.1éšã®FeSO4ãš
0.3éšã®ããŒããã«ïŒšãæ¥æ¬æ²¹è(æ ª)補ïŒïœâããã«
ãã€ããããŒãªããµã€ãïŒãã300éšã®æ°Žã«æº¶è§£ã
ã氎溶液äžã«æµžæŒ¬ãã70âã«ãŠïŒæéåå¿ãããŠ
ã«ã«ããã·ã¬ãŒãå¡©ãã€ãœãã¬ã³åäœãããïŒã¢
ã«ïŒ å°å ¥ããããã®ã«ããŒãã«ãã·ã¯ã©ã·ãªã³æ°Ž
溶液ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«70âã«ãŠïŒæé
浞挬ããåŸãåãåºããŠå®€æž©ã«ãŠä¹Ÿç¥ããã
ãªãŒã»ã«ããŒãã«ïŒæ¥æ¬ã·ã€ãŒãŠãã(æ ª)補ã100
éšãã20éšã®ç¡æ°Žãã¬ã€ã³é žãš0.1éšã®FeSO4ãš
0.3éšã®ããŒããã«ïŒšãæ¥æ¬æ²¹è(æ ª)補ïŒïœâããã«
ãã€ããããŒãªããµã€ãïŒãã300éšã®æ°Žã«æº¶è§£ã
ã氎溶液äžã«æµžæŒ¬ãã70âã«ãŠïŒæéåå¿ãããŠ
ã«ã«ããã·ã¬ãŒãå¡©ãã€ãœãã¬ã³åäœãããïŒã¢
ã«ïŒ å°å ¥ããããã®ã«ããŒãã«ãã·ã¯ã©ã·ãªã³æ°Ž
溶液ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«70âã«ãŠïŒæé
浞挬ããåŸãåãåºããŠå®€æž©ã«ãŠä¹Ÿç¥ããã
ãã®ã«ããŒãã«ã«ã€ããŠè©Šéšèã«Sarcina
lutea ATCC9341ãçšããŠå®æœäŸïŒãšåæ§ã®æŽ»æ§
ãã¹ããè¡ã€ããšããã30æ¥ç®ã®è©Šéšå°¿ã«ã€ããŠ
ãé»æ¢åã¯çããŠããã
lutea ATCC9341ãçšããŠå®æœäŸïŒãšåæ§ã®æŽ»æ§
ãã¹ããè¡ã€ããšããã30æ¥ç®ã®è©Šéšå°¿ã«ã€ããŠ
ãé»æ¢åã¯çããŠããã
å®æœäŸ ïŒ
å®æœäŸïŒã§åŸãããé
žç¡æ°Žç©åºã®å°å
¥ãããå°
å°¿ã«ããŒãã«ã10wtïŒ ããªãšãã¬ã³ã€ãã³æ°Žæº¶
液ã«ïŒâã«ãŠ30åé浞挬ããåŒãç¶ããŠ2wtïŒ
ïŒNâ²âãžã·ã¯ãããã·ã«ã«ãŒããžã€ããã®ã¡
ã¿ããŒã«æº¶æ¶²ã«ïŒâã«ãŠ20åé浞挬ããã€ãã§ã¡
ã¿ããŒã«ã§æŽæµããæ°ŽæŽåŸã也ç¥ãããããã«ã
ã®ã«ããŒãã«ãèåãšãã«ã®å«æ°Žãšã¿ããŒã«æº¶æ¶²
ïŒãšã¿ããŒã«ãšæ°Žã®çéæ··å液ã«3.3wtïŒ ã®èåãš
ãã«ã溶解ãããã®ïŒã«30âã«ãŠïŒæé浞挬ãã
ã€ãã§ãšã¿ããŒã«ãšæ°Žã®çéæ··å液ã«ãŠååæŽæµ
ãããæŽæµåŸã®ã«ããŒãã«ãã»ãã¢ããã³ãããª
ãŠã 氎溶液ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«å®€æž©äžïŒ
æé浞挬ããåŸãæ°ŽæŽïŒä¹Ÿç¥ããŠãæçç©è³ªãã€
ãªã³çµåãããå°å°¿ã«ããŒãã«ãåŸãã
å°¿ã«ããŒãã«ã10wtïŒ ããªãšãã¬ã³ã€ãã³æ°Žæº¶
液ã«ïŒâã«ãŠ30åé浞挬ããåŒãç¶ããŠ2wtïŒ
ïŒNâ²âãžã·ã¯ãããã·ã«ã«ãŒããžã€ããã®ã¡
ã¿ããŒã«æº¶æ¶²ã«ïŒâã«ãŠ20åé浞挬ããã€ãã§ã¡
ã¿ããŒã«ã§æŽæµããæ°ŽæŽåŸã也ç¥ãããããã«ã
ã®ã«ããŒãã«ãèåãšãã«ã®å«æ°Žãšã¿ããŒã«æº¶æ¶²
ïŒãšã¿ããŒã«ãšæ°Žã®çéæ··å液ã«3.3wtïŒ ã®èåãš
ãã«ã溶解ãããã®ïŒã«30âã«ãŠïŒæé浞挬ãã
ã€ãã§ãšã¿ããŒã«ãšæ°Žã®çéæ··å液ã«ãŠååæŽæµ
ãããæŽæµåŸã®ã«ããŒãã«ãã»ãã¢ããã³ãããª
ãŠã 氎溶液ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«å®€æž©äžïŒ
æé浞挬ããåŸãæ°ŽæŽïŒä¹Ÿç¥ããŠãæçç©è³ªãã€
ãªã³çµåãããå°å°¿ã«ããŒãã«ãåŸãã
åŸãããã«ããŒãã«ãçšããŠå®æœäŸïŒãšåæ§ã®
掻æ§ãã¹ããè¡ã€ããšããã40æ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠãé»æ¢åãçãã掻æ§ãªæçç©è³ªãå°¿äžã«å
åšããããšã確èªãããã
掻æ§ãã¹ããè¡ã€ããšããã40æ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠãé»æ¢åãçãã掻æ§ãªæçç©è³ªãå°¿äžã«å
åšããããšã確èªãããã
å®æœäŸ ïŒ
ã·ãªã³ãŒã³å°å°¿ã«ããŒãã«ãã¢ãŒã¬ã€ã«ã»ã·ãª
ã³ãŒã³ã»ããªãŒãªãŒã»ã«ããŒãã«ïŒæ¥æ¬ã·ã€ãŒãŠ
ãã(æ ª)補ããé 次ãäžèšã®åŠçãè¡ã€ãã
ã³ãŒã³ã»ããªãŒãªãŒã»ã«ããŒãã«ïŒæ¥æ¬ã·ã€ãŒãŠ
ãã(æ ª)補ããé 次ãäžèšã®åŠçãè¡ã€ãã
ïŒ 20wtïŒ
ã®ã°ã«ã¿ã«ã¢ã«ããããšïŒïŒ15Mãª
ã³é žç·©è¡æ¶²ïŒPH7.5ïŒãšã®ç容éæ··å液äžã«ïŒ
âã§30åéé眮åŸã宀枩ã§ïŒæé也ç¥ããã
ã³é žç·©è¡æ¶²ïŒPH7.5ïŒãšã®ç容éæ··å液äžã«ïŒ
âã§30åéé眮åŸã宀枩ã§ïŒæé也ç¥ããã
ïŒ 10wtïŒ
ã®ããªãšãã¬ã³ã€ãã³æ°Žæº¶æ¶²äžã«å®€
æž©ã§ïŒæéé眮åŸãæ°ŽæŽããã
æž©ã§ïŒæéé眮åŸãæ°ŽæŽããã
ïŒ å®æœäŸïŒãšåæ§ã«èåãšãã«ã®å«æ°Žãšã¿ããŒ
ã«æº¶æ¶²ã§åŠçããæŽæµããã
ã«æº¶æ¶²ã§åŠçããæŽæµããã
ïŒ ã¡ãã·ãªã³æ°Žæº¶æ¶²ã50mgïŒã«äŸ¡ïŒïŒ100mlã
äžã«ïŒâã§24æéé眮åŸãåãåºããŠæ°ŽæŽïŒä¹Ÿ
ç¥ããã
äžã«ïŒâã§24æéé眮åŸãåãåºããŠæ°ŽæŽïŒä¹Ÿ
ç¥ããã
äžèšã®åŠçãè¡ã€ãã«ããŒãã«ã«ã€ããŠè©Šéšè
ã«Sarcina lutea ATCC9341ãçšããŠå®æœäŸïŒãš
åæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããã35æ¥ç®ã®è©Šéš
å°¿ã«ã€ããŠãé»æ¢åãçããã
ã«Sarcina lutea ATCC9341ãçšããŠå®æœäŸïŒãš
åæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããã35æ¥ç®ã®è©Šéš
å°¿ã«ã€ããŠãé»æ¢åãçããã
å®æœäŸ ïŒïŒïŒ
C.G.Gebeleinããžã€ãŒãã«ã»ãªãã»ãã¯ãã¢ã¬
ããŠãŒã«ã»ãµã€ãšã³ã¹ã»ã±ãã¹ããªãŒïŒ5433
ïŒ1970ïŒããã®æ¹æ³ã«åŸããå®æœäŸïŒã§çšãã倩ç¶
ãŽã å°å°¿ã«ããŒãã«ã®å£é¢ã«ãšãŒãã€ãœã·ã¢ããŒ
ãåºãå°å ¥ããã®ã¡ã30wtïŒ ã®ããªãšãã¬ã³ã€
ãã³æ°Žæº¶æ¶²ã«æµžæŒ¬ãã浞挬åŸçŽã¡ã«åãåºã120
âã«ãŠ60åéç±åŠçãè¡ã€ãåŸãå®æœäŸïŒãšåæ§
ã«ããŠèåãšãã«ã®å«æ°Žãšã¿ããŒã«æº¶æ¶²ã§åŠç
ããæŽæµããã
ããŠãŒã«ã»ãµã€ãšã³ã¹ã»ã±ãã¹ããªãŒïŒ5433
ïŒ1970ïŒããã®æ¹æ³ã«åŸããå®æœäŸïŒã§çšãã倩ç¶
ãŽã å°å°¿ã«ããŒãã«ã®å£é¢ã«ãšãŒãã€ãœã·ã¢ããŒ
ãåºãå°å ¥ããã®ã¡ã30wtïŒ ã®ããªãšãã¬ã³ã€
ãã³æ°Žæº¶æ¶²ã«æµžæŒ¬ãã浞挬åŸçŽã¡ã«åãåºã120
âã«ãŠ60åéç±åŠçãè¡ã€ãåŸãå®æœäŸïŒãšåæ§
ã«ããŠèåãšãã«ã®å«æ°Žãšã¿ããŒã«æº¶æ¶²ã§åŠç
ããæŽæµããã
ãŸããå®æœäŸïŒã§çšãã倩ç¶ãŽã å°å°¿ã«ããŒã
ã«ãããŒãããµ3Mãæ¥æ¬æ²¹è(æ ª)補ãïŒïŒïŒâãã¹
ïŒïœâããã«ããŒãªãã·ïŒïŒïŒïŒïŒïŒâããªã¡ã
ã«ã·ã¯ããããµã³ãäžã«å®€æž©äž30åé浞挬ãã
åŸã20wtïŒ æ°Žæº¶æ¶²ããªã¢ããïŒâSO3Naå«æé
ïŒã¢ã«ïŒ ïŒæ°Žæº¶æ¶²ã«å®€æž©äžïŒåé浞挬ããåãåº
ããŠ140âã§15æéçªçŽ äžã§ç±åŠçãè¡ã€ãã
ã«ãããŒãããµ3Mãæ¥æ¬æ²¹è(æ ª)補ãïŒïŒïŒâãã¹
ïŒïœâããã«ããŒãªãã·ïŒïŒïŒïŒïŒïŒâããªã¡ã
ã«ã·ã¯ããããµã³ãäžã«å®€æž©äž30åé浞挬ãã
åŸã20wtïŒ æ°Žæº¶æ¶²ããªã¢ããïŒâSO3Naå«æé
ïŒã¢ã«ïŒ ïŒæ°Žæº¶æ¶²ã«å®€æž©äžïŒåé浞挬ããåãåº
ããŠ140âã§15æéçªçŽ äžã§ç±åŠçãè¡ã€ãã
äžèšã®ããã«ããŠåŸãããå°å°¿ã«ããŒãã«ãã
ãããã»ãã¢ããã³ãããªãŠã 氎溶液ã50mgïŒã«
䟡ïŒïŒ100mlãããã³ç¡«é žãžãã«ãžã³æ°Žæº¶æ¶²ã500
mgïŒã«äŸ¡ïŒïŒ100mlãã«ããããPHãïŒãšïŒã«èª¿
æŽããªããïŒâã«ãŠïŒæé浞挬ããããã®ãã®ã
çšããŠå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšã
ããäž¡è ãšã40æ¥ç®ã®è©Šæå°¿ã«ã€ããŠãé»æ¢åã
çããã
ãããã»ãã¢ããã³ãããªãŠã 氎溶液ã50mgïŒã«
䟡ïŒïŒ100mlãããã³ç¡«é žãžãã«ãžã³æ°Žæº¶æ¶²ã500
mgïŒã«äŸ¡ïŒïŒ100mlãã«ããããPHãïŒãšïŒã«èª¿
æŽããªããïŒâã«ãŠïŒæé浞挬ããããã®ãã®ã
çšããŠå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšã
ããäž¡è ãšã40æ¥ç®ã®è©Šæå°¿ã«ã€ããŠãé»æ¢åã
çããã
å®æœäŸ ïŒ
å®æœäŸïŒã§çšããã·ãªã³ãŒã³å°å°¿ã«ããŒãã«ã
γâã¢ãããããã«ããªãšããã·ã·ã©ã³ã®10wt
ïŒ ã¯ãããã«ã 溶液ã«å®€æž©äžã§24æé浞挬ããŠã®
ã¡ã¯ãããã«ã ã§æŽæµãã也ç¥ããã也ç¥åŸã®ã«
ããŒãã«ãGuntrez169ãGAF補ãç¡æ°Žãã¬ã€ã³é ž
âã¡ãã«ããã«ãšãŒãã«ã®ïŒå¯ŸïŒå ±éåäœãã®ïŒ
ïŒ ã¢ã»ãã³æº¶æ¶²ã«å®€æž©äž60åé浞挬ããåŸãã¢ã»
ãã³ã§æŽæµãã也ç¥ããããã®ãã®ã100âç±æ°Ž
äžã«ïŒæé浞挬ããã®ã¡åãåºã空å·åŸãã²ã³ã¿
ãã€ã·ã³ã®ïŒïŒ15Mãªã³é žç·©è¡æ¶²ïŒPH7.5ïŒæº¶æ¶²
ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«ïŒâã«ãŠïŒæé浞挬
ããã€ãã§æ°ŽæŽã也ç¥ããã
γâã¢ãããããã«ããªãšããã·ã·ã©ã³ã®10wt
ïŒ ã¯ãããã«ã 溶液ã«å®€æž©äžã§24æé浞挬ããŠã®
ã¡ã¯ãããã«ã ã§æŽæµãã也ç¥ããã也ç¥åŸã®ã«
ããŒãã«ãGuntrez169ãGAF補ãç¡æ°Žãã¬ã€ã³é ž
âã¡ãã«ããã«ãšãŒãã«ã®ïŒå¯ŸïŒå ±éåäœãã®ïŒ
ïŒ ã¢ã»ãã³æº¶æ¶²ã«å®€æž©äž60åé浞挬ããåŸãã¢ã»
ãã³ã§æŽæµãã也ç¥ããããã®ãã®ã100âç±æ°Ž
äžã«ïŒæé浞挬ããã®ã¡åãåºã空å·åŸãã²ã³ã¿
ãã€ã·ã³ã®ïŒïŒ15Mãªã³é žç·©è¡æ¶²ïŒPH7.5ïŒæº¶æ¶²
ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«ïŒâã«ãŠïŒæé浞挬
ããã€ãã§æ°ŽæŽã也ç¥ããã
ãã®ã«ããŒãã«ã«ã€ããŠè©Šéšèã«Staphy
lococcus epidermidis ATCC12228ãçšããŠå®æœ
äŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããã40æ¥ç®
ã®è©Šæå°¿ã«ã€ããŠãé»æ¢åãçããã
lococcus epidermidis ATCC12228ãçšããŠå®æœ
äŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããã40æ¥ç®
ã®è©Šæå°¿ã«ã€ããŠãé»æ¢åãçããã
å®æœäŸ ïŒ
å®æœäŸïŒã§çšãã倩ç¶ãŽã å°å°¿ã«ããŒãã«ãã
ãã°ããŽãŒã«400ãæŸæ¬æ²¹è(æ ª)補ãããªãšãã¬ã³ã°
ãªã³ãŒã«ãïŒéšãšGuntrez169.2éšããããã©ãã
ããã©ã³ãšæ°Žãšã®ç容éæ··å液100éšã«æº¶è§£ãã
溶液ã«å®€æž©äžã«ïŒåé浞挬ããåŸãçªçŽ é°å²æ°ã§
140âã«ãŠïŒæéç±åŠçãè¡ã€ããåŸãããã«ã
ãŒãã«ã100âã®ç±æ°Žäžã«ïŒæé浞挬åŸã空å·ãã
ã€ãã§ç¡«é žããªããã·ã³ïŒ¢æ°Žæº¶æ¶²ã50000åäœïŒ
100mlãã«PHãïŒã«èª¿æŽããªããïŒâã«ãŠ30åé
浞挬ããã
ãã°ããŽãŒã«400ãæŸæ¬æ²¹è(æ ª)補ãããªãšãã¬ã³ã°
ãªã³ãŒã«ãïŒéšãšGuntrez169.2éšããããã©ãã
ããã©ã³ãšæ°Žãšã®ç容éæ··å液100éšã«æº¶è§£ãã
溶液ã«å®€æž©äžã«ïŒåé浞挬ããåŸãçªçŽ é°å²æ°ã§
140âã«ãŠïŒæéç±åŠçãè¡ã€ããåŸãããã«ã
ãŒãã«ã100âã®ç±æ°Žäžã«ïŒæé浞挬åŸã空å·ãã
ã€ãã§ç¡«é žããªããã·ã³ïŒ¢æ°Žæº¶æ¶²ã50000åäœïŒ
100mlãã«PHãïŒã«èª¿æŽããªããïŒâã«ãŠ30åé
浞挬ããã
åŸãããã«ããŒãã«ã«ã€ããŠè©ŠéšèãšããŠ
Escherichia coli NIHJãçšããŠå®æœäŸïŒãšåæ§
ã®æŽ»æ§ãã¹ããè¡ã€ããšããã40æ¥ç®ã®è©Šæå°¿ã«
ã€ããŠãé»æ¢åãçããã
Escherichia coli NIHJãçšããŠå®æœäŸïŒãšåæ§
ã®æŽ»æ§ãã¹ããè¡ã€ããšããã40æ¥ç®ã®è©Šæå°¿ã«
ã€ããŠãé»æ¢åãçããã
å®æœäŸ ïŒ
å®æœäŸïŒã§çšããã·ãªã³ãŒã³å°å°¿ã«ããŒãã«ã
KE 42SâRTVïŒä¿¡è¶ã·ãªã³ãŒã³è£œãã·ãªã³ã³ç³»
ãŽã ã³ã³ããŠã³ããã«å®€æž©äžã«ãŠïŒåé浞挬åŸã
100âã«ãŠïŒæéç±åŠçãè¡ããå·åŽåŸãåŒãç¶
ããŠããªããã«ã¢ã«ã³ãŒã«ïŒéå床1700ãå®å šã
ãåïŒïŒéšãšGuntrez169.4éšã100éšã®æ°Žã«æº¶è§£
ãã溶液ã«å®€æž©äžã«10åé浞挬ãã160âã«ãŠïŒ
æéç±åŠçãããåŸãããã«ããŒãã«ã100âã®
ç±æ°Žäžã«ïŒæé浞挬ããåŸã空å·ãã²ã³ã¿ãã€ã·
ã³ã®æ°Žæº¶æ¶²ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«PHãïŒã«
調æŽããªããïŒâã«ãŠ30åé浞挬ããã
KE 42SâRTVïŒä¿¡è¶ã·ãªã³ãŒã³è£œãã·ãªã³ã³ç³»
ãŽã ã³ã³ããŠã³ããã«å®€æž©äžã«ãŠïŒåé浞挬åŸã
100âã«ãŠïŒæéç±åŠçãè¡ããå·åŽåŸãåŒãç¶
ããŠããªããã«ã¢ã«ã³ãŒã«ïŒéå床1700ãå®å šã
ãåïŒïŒéšãšGuntrez169.4éšã100éšã®æ°Žã«æº¶è§£
ãã溶液ã«å®€æž©äžã«10åé浞挬ãã160âã«ãŠïŒ
æéç±åŠçãããåŸãããã«ããŒãã«ã100âã®
ç±æ°Žäžã«ïŒæé浞挬ããåŸã空å·ãã²ã³ã¿ãã€ã·
ã³ã®æ°Žæº¶æ¶²ã50mgïŒã«äŸ¡ïŒïŒ100mlãã«PHãïŒã«
調æŽããªããïŒâã«ãŠ30åé浞挬ããã
åŸãããã«ããŒãã«ã«ã€ããŠè©Šéšèã«
Staphylococcus epidermidis ATCC12228ãçš
ããŠå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšã
ãã40æ¥ç®ã®è©Šéšèã«ã€ããŠãé»æ¢åãçããã
Staphylococcus epidermidis ATCC12228ãçš
ããŠå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšã
ãã40æ¥ç®ã®è©Šéšèã«ã€ããŠãé»æ¢åãçããã
å®æœäŸ ïŒ
倩ç¶ãŽã å°å°¿ã«ããŒãã«ãã¢ãŒã¬ã€ã«ã»ããªãŒ
ãªãŒã»ã«ããŒãã«ïŒæ¥æ¬ã·ã€ãŒãŠãã(æ ª)補ããã
ããå床99.9ã¢ã«ïŒ ãéå床1700ã®ããªããã«ã¢
ã«ã³ãŒã«9000éšãšéã¯ãã é žã¢ã³ã¢ããŠã ïŒéšã
100000éšã®æ°Žã«æº¶è§£ãã溶液ã«ææã«ãŠæµžæŒ¬ãã
çŽã¡ã«åŒãäžããè¢å ç¯ã§å ç §å°ãïŒåéè¡ã€ã
åŸã80âã§ïŒæé也ç¥ããããããåŸã«çªçŽ é°å²
æ°ã«ãŠ200âã§ïŒåéç±åŠçãè¡ã€ããåŒãç¶ã
ãã®ããªããã«ã¢ã«ã³ãŒã«ã®ã³ãŒãã€ã³ã°ããã
å°å°¿ã«ããŒãã«ã10wtïŒ ã®ã¢ãã¯ãã«é ¢é žãã
ãªãŠã ã®æ°Žæº¶æ¶²ã«å®€æž©äžã§ïŒæéé眮ããåŸã
10wtïŒ ã®æ°Žé žåãããªãŠã 氎溶液ãæ·»å ãã70
âã«ææž©ããŠïŒæéåå¿ãããã
ãªãŒã»ã«ããŒãã«ïŒæ¥æ¬ã·ã€ãŒãŠãã(æ ª)補ããã
ããå床99.9ã¢ã«ïŒ ãéå床1700ã®ããªããã«ã¢
ã«ã³ãŒã«9000éšãšéã¯ãã é žã¢ã³ã¢ããŠã ïŒéšã
100000éšã®æ°Žã«æº¶è§£ãã溶液ã«ææã«ãŠæµžæŒ¬ãã
çŽã¡ã«åŒãäžããè¢å ç¯ã§å ç §å°ãïŒåéè¡ã€ã
åŸã80âã§ïŒæé也ç¥ããããããåŸã«çªçŽ é°å²
æ°ã«ãŠ200âã§ïŒåéç±åŠçãè¡ã€ããåŒãç¶ã
ãã®ããªããã«ã¢ã«ã³ãŒã«ã®ã³ãŒãã€ã³ã°ããã
å°å°¿ã«ããŒãã«ã10wtïŒ ã®ã¢ãã¯ãã«é ¢é žãã
ãªãŠã ã®æ°Žæº¶æ¶²ã«å®€æž©äžã§ïŒæéé眮ããåŸã
10wtïŒ ã®æ°Žé žåãããªãŠã 氎溶液ãæ·»å ãã70
âã«ææž©ããŠïŒæéåå¿ãããã
åŸãããã«ããŒãã«ãå®æœäŸïŒãšåæ§ã«ç¡«é
žãž
ãã«ã·ã³åŠçããå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ãã
è¡ã€ããšããã40æ¥ç®ã®è©Šéšå°¿ã«é¢ããŠãé»æ¢å
ãèªããããã
ãã«ã·ã³åŠçããå®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ãã
è¡ã€ããšããã40æ¥ç®ã®è©Šéšå°¿ã«é¢ããŠãé»æ¢å
ãèªããããã
æ¯èŒäŸ ïŒ
ã¢ãã¯ãã«é
¢é
žåŠç以éã®åŠçãè¡ããªãã€ã
以å€ã¯å®æœäŸïŒãšå šãåæ§ã«ããŠã«ããŒãã«ãåŸ
ããåŸãããã«ããŒãã«ã«ã€ããŠå®æœäŸïŒãšåæ§
ã«ç¡«é žãžãã«ã·ã³åŠçãè¡ããå®æœäŸïŒãšåæ§ã®
掻æ§ãã¹ããè¡ã€ããšããã10æ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠé»æ¢åãèªããããªããªã€ãã
以å€ã¯å®æœäŸïŒãšå šãåæ§ã«ããŠã«ããŒãã«ãåŸ
ããåŸãããã«ããŒãã«ã«ã€ããŠå®æœäŸïŒãšåæ§
ã«ç¡«é žãžãã«ã·ã³åŠçãè¡ããå®æœäŸïŒãšåæ§ã®
掻æ§ãã¹ããè¡ã€ããšããã10æ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠé»æ¢åãèªããããªããªã€ãã
å®æœäŸ 10
枡蟺æºãã®æ¹æ³ã人工èåšïŒ(1)ïŒ206ïŒ1978ã
ã«åŸã€ãŠåŸãããªãšãã¬ã³âã³ã©ãŒã²ã³åæé«å
åè€åäœãçšããŠå°å°¿ã«ããŒãã«ãæ圢ãããã
ã®ã«ããŒãã«ãããªããã·ã³ïŒ¢ã®æ°Žæº¶æ¶²ãïŒïœïŒ
100mlãã«PHãïŒã«ä¿ã¡ãªããïŒâã«ãŠïŒæé浞
挬ããã
ã«åŸã€ãŠåŸãããªãšãã¬ã³âã³ã©ãŒã²ã³åæé«å
åè€åäœãçšããŠå°å°¿ã«ããŒãã«ãæ圢ãããã
ã®ã«ããŒãã«ãããªããã·ã³ïŒ¢ã®æ°Žæº¶æ¶²ãïŒïœïŒ
100mlãã«PHãïŒã«ä¿ã¡ãªããïŒâã«ãŠïŒæé浞
挬ããã
åŸãããã«ããŒãã«ã«ã€ããŠè©Šéšèã«
Bordetella bronchiseptica ATCC4617ãçšããŠ
å®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããã40
æ¥ç®ã®è©Šéšå°¿ã«ã€ããŠãé»æ¢åãèªããããã
Bordetella bronchiseptica ATCC4617ãçšããŠ
å®æœäŸïŒãšåæ§ã®æŽ»æ§ãã¹ããè¡ã€ããšããã40
æ¥ç®ã®è©Šéšå°¿ã«ã€ããŠãé»æ¢åãèªããããã
æ¯èŒäŸ ïŒ
å®æœäŸ10ãšåæ§ã«ããŠããªãšãã¬ã³âã³ã©ãŒã²
ã³åæé«ååè€åäœãããªãå°å°¿ã«ããŒãã«ãæ
圢ããããã®ã«ããŒãã«ã0.1Mã®ïŒ®âãããã
ã·ãµã¯ã·ã€ãã氎溶液ã«æµžæŒ¬ããããæ¹æããªã
ããïŒâãšãã«âïŒâïŒïŒâãžã¡ãã«ã¢ãããã
ãã«ïŒâã«ãŒããžã€ããã0.1Mæ·»å ãã0.1Nâ
NaOHã§PHãïŒãïŒã«ä¿ã¡ã€ã€å®€æž©ã§çŽ12æé
åå¿ããããåå¿åŸã®ã«ããŒãã«ãèžçæ°Žã§æ°å
ããæŽæµããåŸãããªããã·ã³ïŒ¢ã®0.06Mãªã³é ž
ç·©è¡æ¶²ïŒPH7.4ïŒãïŒïœïŒ100mlãã«ïŒâã«ãŠïŒæ
é浞挬ããŠãããªããã·ã³ïŒ¢ãå ±æçµåããå°å°¿
ã«ããŒãã«ãåŸãã
ã³åæé«ååè€åäœãããªãå°å°¿ã«ããŒãã«ãæ
圢ããããã®ã«ããŒãã«ã0.1Mã®ïŒ®âãããã
ã·ãµã¯ã·ã€ãã氎溶液ã«æµžæŒ¬ããããæ¹æããªã
ããïŒâãšãã«âïŒâïŒïŒâãžã¡ãã«ã¢ãããã
ãã«ïŒâã«ãŒããžã€ããã0.1Mæ·»å ãã0.1Nâ
NaOHã§PHãïŒãïŒã«ä¿ã¡ã€ã€å®€æž©ã§çŽ12æé
åå¿ããããåå¿åŸã®ã«ããŒãã«ãèžçæ°Žã§æ°å
ããæŽæµããåŸãããªããã·ã³ïŒ¢ã®0.06Mãªã³é ž
ç·©è¡æ¶²ïŒPH7.4ïŒãïŒïœïŒ100mlãã«ïŒâã«ãŠïŒæ
é浞挬ããŠãããªããã·ã³ïŒ¢ãå ±æçµåããå°å°¿
ã«ããŒãã«ãåŸãã
åŸãããã«ããŒãã«ã«ã€ããŠå®æœäŸ10ãšåæ§ã®
掻æ§ãã¹ããè¡ã€ããšãããé»æ¢åã¯çããªãã€
ãã
掻æ§ãã¹ããè¡ã€ããšãããé»æ¢åã¯çããªãã€
ãã
å®æœäŸ 11
ç¡«é
žããªããã·ã³ïŒ¢æ°Žæº¶æ¶²ã«æµžæŒ¬ãã代ããã«
ç¡«é žããªããã·ã³ïŒ¢è»èãå¡åžãã以å€ã¯å®æœäŸ
ïŒãšå šãåæ§ã«ããŠã«ããŒãã«ãåŸãã
ç¡«é žããªããã·ã³ïŒ¢è»èãå¡åžãã以å€ã¯å®æœäŸ
ïŒãšå šãåæ§ã«ããŠã«ããŒãã«ãåŸãã
åŸãããã«ããŒãã«ã«ã€ããŠå®æœäŸïŒãšåæ§ã®
掻æ§ãã¹ããè¡ã€ããšããã20æ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠãé»æ¢åãèªããããã
掻æ§ãã¹ããè¡ã€ããšããã20æ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠãé»æ¢åãèªããããã
æ¯èŒäŸ ïŒ
å®æœäŸïŒã§çšããæªåŠçã®å€©ç¶ãŽã å°å°¿ã«ããŒ
ãã«ã«å®æœäŸ11ã«çšããç¡«é žããªããã·ã³ïŒ¢è»è
ãå¡åžããã
ãã«ã«å®æœäŸ11ã«çšããç¡«é žããªããã·ã³ïŒ¢è»è
ãå¡åžããã
åŸãããã«ããŒãã«ã«ã€ããŠå®æœäŸ11ãšåæ§ã®
掻æ§ãã¹ããè¡ã€ããšãããïŒæ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠé»æ¢åãèªããããªããªã€ãã
掻æ§ãã¹ããè¡ã€ããšãããïŒæ¥ç®ã®è©Šéšå°¿ã«ã€
ããŠé»æ¢åãèªããããªããªã€ãã
Claims (1)
- ïŒ ãªã¬ãã€ã³ç³»éåäœãŸãã¯ãžãšã³ç³»éåäœãŸ
ãã¯ã·ãªã³ã³ç³»éåäœãçŽ æãšããå°å°¿ã«ããŒã
ã«ã«ãããŠã該ã«ããŒãã«ã®å å£ãŸãã¯å€å£ã«æ
çç©è³ªãã€ãªã³çµåãããŠããããšãç¹åŸŽãšãã
å°¿è·¯ææé²æ¢èœãæããå°å°¿ã«ããŒãã«ã
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56081474A JPS57195471A (en) | 1981-05-27 | 1981-05-27 | Urine discharging cathetel having ureter infection preventing function |
| EP82302725A EP0065884B1 (en) | 1981-05-27 | 1982-05-27 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
| DE8282302725T DE3272706D1 (en) | 1981-05-27 | 1982-05-27 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
| US06/382,743 US4539234A (en) | 1981-05-27 | 1982-05-27 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
| US06/734,726 US4642104A (en) | 1981-05-27 | 1985-06-14 | Urethral catheter capable of preventing urinary tract infection and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56081474A JPS57195471A (en) | 1981-05-27 | 1981-05-27 | Urine discharging cathetel having ureter infection preventing function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57195471A JPS57195471A (en) | 1982-12-01 |
| JPH0225625B2 true JPH0225625B2 (ja) | 1990-06-05 |
Family
ID=13747394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56081474A Granted JPS57195471A (en) | 1981-05-27 | 1981-05-27 | Urine discharging cathetel having ureter infection preventing function |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57195471A (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4895566A (en) * | 1986-07-25 | 1990-01-23 | C. R. Bard, Inc. | Coating medical devices with cationic antibiotics |
-
1981
- 1981-05-27 JP JP56081474A patent/JPS57195471A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57195471A (en) | 1982-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4642104A (en) | Urethral catheter capable of preventing urinary tract infection and process for producing the same | |
| JPH10328293A (ja) | å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| US6416546B1 (en) | Medical device and production method thereof | |
| JP2008119499A (ja) | åºäœã«èŠªæ°Žæ§è¢«èã圢æããæ¹æ³ããã³ãã®ãããªè¢«èãåããåºäœãç¹ã«å»ççšè£ 眮 | |
| EP1131112B2 (en) | A method for sterilising a medical device having a hydrophilic coating | |
| JP5685539B2 (ja) | å¶åŸ¡æŸåºå¯èœãªæèå€ãåããå»çããã€ã¹ | |
| CN101212906B (zh) | çšäºåšå»çè£ çœ®äžæå¶åŸ®çç©èèççé¿åå¢æ®çæ埮çç©ç»åç© | |
| US20070093894A1 (en) | Incorporation of antimicrobial combinations onto devices to reduce infection | |
| CN112587734A (zh) | äžç§åºäºä»¿çå€å·Žèºçå€åèœæ¶å±åå ¶å¶å€æ¹æ³ååºçš | |
| Yuan et al. | Nuclease-functionalized poly (styrene-b-isobutylene-b-styrene) surface with anti-infection and tissue integration bifunctions | |
| JPH0783761B2 (ja) | å»ççšå · | |
| Dunkirk et al. | Photochemical coatings for the prevention of bacterial colonization | |
| Lakshmi et al. | Bacterial adhesion onto azidated poly (vinyl chloride) surfaces | |
| WO2023102436A1 (en) | Ionic polymers for medical device applications | |
| US20230166001A1 (en) | Ionic Polymers for Medical Device Applications | |
| US20230166007A1 (en) | Ionic Polymers For Medical Device Applications | |
| CN114177359B (zh) | äžç§æèæ¶å±åå ¶å¶å€æ¹æ³ååºçš | |
| JPH0224544B2 (ja) | ||
| JPH10328294A (ja) | å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JP3776194B2 (ja) | å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| EP4496840B1 (en) | Surface activation of silicone | |
| JPH0310341B2 (ja) | ||
| JP2003299726A (ja) | äœå æ¿å ¥å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JP2003299725A (ja) | äœå æ¿å ¥å»ççšå ·åã³ãã®è£œé æ¹æ³ | |
| JPS61122869A (ja) | å»ççšå ·ããã³ãã®è£œé æ¹æ³ |